Lanthanide (III) complexes
Water-soluble lanthanide(III) complexes with tailored ligands address the limitations of conventional systems, achieving efficient up-conversion and biocompatibility for bioimaging by using imidazolium-functionalized and benzenetriol-derived ligands, enhancing tissue penetration and reducing radiation exposure.
Patent Information
- Application Number
- PCT/US2026/027414
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-05-09
- Filing Date
- 2026-05-08
- Publication Date
- 2026-11-12
AI Technical Summary
Conventional lanthanide-based up-conversion systems suffer from low water solubility, limited tissue penetration, potential accumulation in biological systems, and challenges in tuning optical properties, making them unsuitable for efficient bioimaging applications.
Development of water-soluble lanthanide(III) complexes with imidazolium-functionalized and benzenetriol-derived ligands, naphthylsalophen ligands functionalized with sulfonate groups, and other solubilizing functional groups to enhance biocompatibility and up-conversion efficiency.
The complexes exhibit efficient up-conversion capabilities, penetrate biological tissues, and demonstrate biocompatibility, enabling effective bioimaging applications with reduced exposure to high-energy radiation.
Smart Images

Figure US2026027414_12112026_PF_FP_ABST
Abstract
Description
PATENTAttorney Docket No.: TXTU / 0012PCLANTHANIDE(III) COMPLEXESSTATEMENT OF FEDERALLY FUNDED RESEARCH
[0001] This invention was made with government support under Grant No. CHE2154848 awarded by the National Science Foundation. The government has certain rights in the invention.BACKGROUNDField
[0002] Embodiments of the present disclosure generally relate to water-soluble lanthanide(III) complexes. Specifically, embodiments of the present disclosure may be useful in up-conversion processes, particularly for use in bioimaging applications.Description of the Related Art
[0003] In the medical field, bioimaging is an important process in diagnosing and treating a wide range of medical conditions. Bioimaging generally refers to imaging biological tissues or organisms to better understand physiological processes without invasive procedures. Conventional imaging techniques may require exposure to high-energy radiation, such as ultraviolet or X-ray radiation, which can cause genetic defects, gene alterations, and other cellular damage. Accordingly, there is a need to minimize exposure to such high-energy radiation. Photon up-conversion processes have been explored as an approach to enable excitation with lower-energy radiation while still producing higher-energy emissions suitable for imaging.
[0004] Up-conversion in which two or more photons of a first energy level and corresponding wavelength are absorbed, and one or more photons of a higher energy level and shorter wavelength are emitted. Lanthanide series elements are of particular interest for up-conversion applications due to their electronic structures, including partially filled 4f orbitals that give rise to discrete energy levels. However, direct excitation of lanthanide ions is inefficient due to the forbidden nature of f-f electronic transitions, and therefore typically requires sensitization mechanisms. Conventional up-conversion systems, such as lanthanide-doped nanoparticles, often suffer from limitations including low water solubility, limited tissue penetration,PATENTAttorney Docket No.: TXTU / 0012PCpotential accumulation in biological systems, and challenges in tuning optical properties.
[0005] Accordingly, there remains a need for compounds suitable for biological imaging applications, including those that are water-soluble, biocompatible, capable of efficient up-conversion, and capable of penetrating biological tissues.SUMMARY
[0006] In a first embodiment, a composition is disclosed. The composition includes a lanthanide(l II) complex represented by Formula (I): [Ln2(Lx)3(H2O)], wherein, each Ln is independently a lanthanide(III) ion; and Lxis a ligand, each of the ligands independently comprises an imidazolium-functionalized multidentate ligand derived from an imidazole-substituted aldehyde and a diamine, a benzenetriol-derived multidentate ligand comprising a 1,2,3-trihydroxybenzene moiety, a naphthylsalophen ligand functionalized with one or more sulfonate groups,wherein R is a hydrogen or NaSO3.PATENTAttorney Docket No.: TXTU / 0012PC
[0007] In another embodiment, a composition is disclosed. The composition includes a lanthanide(III) complex represented by Formula (I): [Ln2(Lx)3(H2O)], wherein each Ln2 is independently a lanthanide(III) ion; and each L is independently a ligand.
[0008] In another embodiment, a composition is disclosed. The composition includes a lanthanide(l 11) complex represented by Formula (V): [Ln2(L’x)3H2O], wherein, each Ln is independently a lanthanidefl 11) ion; and each L’xis independently a sulfonated ligand.BRIEF DESCRIPTION OF THE DRAWINGS
[0009] So that the manner in which the above recited features of the present disclosure can be understood in detail, a more particular description of the disclosure, briefly summarized above, may be had by reference to embodiments, some of which are illustrated in the appended drawings. It is to be noted, however, that the appended drawings illustrate only exemplary embodiments and are therefore not to be considered limiting of its scope, may admit to other equally effective embodiments.
[0010] Figures 1A, 1 B, and 1C illustrate a schematic diagram of water-soluble imidazolium-based and benzenetriol-based lanthanide (Ln(lll)) complexes, according to certain embodiments.
[0011] Figure 2 illustrates a schematic diagram of pyridine-based and pyrazine- based naphthylsalophen Ln(lll) complexes, according to certain embodiments.
[0012] Figure 3 illustrates a schematic diagram of the sulfonated naphthylsalophen, the Ln(lll) complex, according to certain embodiments.
[0013] Figure 4 illustrates an exemplary energy level diagram of the up-conversion (UC) process via excited-state absorption or energy-transfer up-conversion, according to certain embodiments.
[0014] Figures 5A and 5B illustrate a mechanistic diagram of forming ligands, according to certain embodiments.PATENTAttorney Docket No.: TXTU / 0012PC
[0015] Figures 6A, 6B, 6C, 6D, and 6E illustrate characterization data for imidazolium and benzenethiol based Ln(lll) complexes, [Ln2(L1)3H2O], according to certain embodiments.
[0016] Figures 7A, 7B, 7C, 7D, and 7E illustrate characterization data for imidazolium and benzenethiol based Ln(lll) complexes, [Ln2(L2)3H2O], according to certain embodiments.
[0017] Figures 8A, 8B, 8C, 8D, and 8E illustrate characterization data for imidazolium and benzenethiol based Ln(lll) complexes, [Ln2(L3)3H2O], according to certain embodiments.
[0018] Figures 9A and 9B illustrate a solid-state up-conversion emission spectrum and a logarithmic plot of the emission intensity, according to certain embodiments.
[0019] Figure 10 illustrates images of the up-conversion solid-state examples, according to certain embodiments.
[0020] Figure 11 illustrates the up-conversion spectra of [Er2(L1)3H2O] in H2O, according to certain embodiments.
[0021] Figure 12 illustrates the cell viability after incubation with Ln(lll) complexes, in certain embodiments.
[0022] Figure 13 illustrates confocal fluorescence images of cells after incubation with Ln(lll) complexes, in certain embodiments.
[0023] Figure 14 illustrates the red and green up-conversion emission in cells after incubation with Ln(lll) complexes, according to certain embodiments.
[0024] Figures 15A, 15B, 15C, 15D, 15E, and 15F illustrate projections of example Ln(lll) complexes, according to certain embodiments.
[0025] Figures 16A and 16B illustrate a solid-state up-conversion emission spectra and a logarithmic plot of the emission intensity, according to certain embodiments.PATENTAttorney Docket No.: TXTU / 0012PC
[0026] Figures 17A and 17B illustrate a solid-state up-conversion emission spectrum and a logarithmic plot of the emission intensity, according to certain embodiments.
[0027] Figure 18 illustrates the two-photon UC emission spectrum of [Ero83Yboi7(L’1)3(MeOH)] in water, according to certain embodiments.
[0028] Figures 19A and 19B illustrate3T as a function of electronegativity and the quantum yield of sensitized emission as a function of3T, according to certain embodiments.
[0029] Figures 20A and 20B illustrate a solid-state up-conversion emission spectrum and a logarithmic plot of the emission intensity, according to certain embodiments.
[0030] Figure 21 illustrates the two-photon UC emission spectra of [Er2(L2)3(H2O)] in H2O and D2O, according to certain embodiments.
[0031] Figure 22 illustrates the two-photon UC emission spectra of [Er2(L3)3(H2O)] and [(Eroi3Ybo.8s)2(L3)3] in the solid state, according to certain embodiments.
[0032] Figures 23A and 23B illustrate normalized UC emission spectra for all substituted complexes disclosed above and a comparison of electron-withdrawing and electron-donating groups, according to certain embodiments.
[0033] To facilitate understanding, identical reference numerals have been used, where possible, to designate identical elements that are common to the figures. It is contemplated that elements and features of one embodiment may be beneficially incorporated in other embodiments without further recitation.DETAILED DESCRIPTION
[0034] Embodiments of the present disclosure generally relate to water-soluble lanthanide(lll) (Ln(III)) complexes. Specifically, embodiments of the present disclosure may be useful in up-conversion processes, particularly for use in bioimaging applications. The Ln(lll) complexes are a composition that at least includes a (Ln(lll)) ion (also referred to as a Ln(lll) metal) and a ligand (L). Ln(lll) ionsPATENTAttorney Docket No.: TXTU / 0012PChave distinctive characteristics, such as light emission due to f-f transitions, which are useful in a variety of applications. As the core 4f orbitals are unaffected by the chemical environment, the emission exhibits high color purity. Long luminescence lifetimes arise from the forbidden nature of the electric-dipole f-f transitions. In bioimaging applications, the forbidden nature allows for time-delayed emission measurements with an increased signal-to-noise ratio. Because transitions are forbidden, direct excitation or sensitization is inefficient; emission is most efficiently sensitized via an attached chromophore, a process known as the antenna effect. These chromophores can be tailored to have specific chemical and physical properties for certain applications; however, the excitation through the antenna effect requires high-energy light, which is unsuitable for biological applications. Sensitization at lower energies is achievable through either two-photon absorption, or through up-conversion (UC). UC refers to a sequence of linear processes, such as excited-state absorption (ESA) and energy-transfer up-conversion (ETU), as illustrated in Figure 4. The sensitizer absorbs multiple low-energy photons, and the activator emits a higher-energy photon. Thus, the aforementioned type of sensitization has become of significant interest for bioimaging applications. For example, as disclosed herein, in the Ln(lll) complexes with one Ln metal, the Ln metal is the activator and the ligand is the sensitizer. In another example, when there is more than one Ln metal within the Ln(lll) complex, a metal operable to absorb near infrared (NIR) light is the sensitizer and transfers the absorbed energy to the second metal and / or the associated ligand, which is the activator.
[0035] Lanthanide-based systems have conventionally been explored for UC imaging, predominantly in lanthanide-doped sodium yttrium fluoride (NaYF4). Lanthanide-based systems are typically nanoparticle-based. When the energy of the excited states of the lanthanides is close, the energy transfer rates improve, and the probability of UC increases in the low-phonon solid-state lattice. The most commonly used Ln(lll) pair is ytterbium, Yb(lll), and erbium, Er(lll), due to the energy match of Yb(lll) (e.g., with an electronic energy level of2F5 / 2, 10,620 cm'1) and Er(III) (e.g., with an electronic energy level of4I11 / 2, 10,350 cm'1) excited states. Moreover, Yb(lll) and Er(lll) have spin-allowed transitions with a high absorption cross-section and long-lived excited states. Figure 4 shows an exemplary energy level diagram illustratingPATENTAttorney Docket No.: TXTU / 0012PCthe UC process through excited state absorption (purple up-arrows on Er(lll)) and energy transfer up-conversion (orange arrows on Yb(III)).
[0036] However, these referenced nanoparticle-based systems frequently exhibit low cellular penetrability and overaccumulation. Ln(III) complexes, on the other hand, are easily derivatized for biocompatibility and solubility. Molecular Ln(lll) UC luminescence with helical pseudo-cryptate multi-metallic chromium and erbium complexes has been conventionally explored, which exhibited NIR to visible UC luminescence in the solid state. Further, conventional methods have isolated a self¬ assembled Er(lll) and zinc(ll) (Zn(ll)) complex and a heteroleptic dinuclear Er(III) complex with a 4,4’-bipyridine-based ligand, which exhibited UC in solution. Isolation of the tris-heteronuclear lanthanide complexes demonstrates cooperative ETU in Yb(lll) and terbium (Tb(lll)) complexes with azamacrocyclic platforms. A Yb(III) / Eu(III) complex isolated with a benzoylacetonate-based ligand that exhibits cooperative ETU luminescence. 2:3 Metal-to-ligand complexes with naphthylsalophen ligands display Er-centered UC emission forthe Erand mixed lanthanide complexes in the solid state. As disclosed herein, the Ln(lll) complexes disclosed expand to include water-soluble complexes, a property necessary for biological work, by substituting the original naphthylsalophen-based ligand with solubilizing functional groups such as sulfonate, phosphonate, imidazolium groups, or combinations thereof. Other solubilizing functional groups may include hydroxide, carboxylate, glycol-like chains, or combinations thereof.
[0037] In one or more embodiments, the Ln(lll) complexes are represented by Formula (I):[Ln2(Lx)3H2O] (I)
[0038] Ln in Formula (I) is a Ln(lll) metal, and L is a ligand, and x denotes which L is coupled to the Ln(lll) complex (e.g., L1denotes a different ligand than L2). In one or more embodiments, the Ln(lll) complexes include more than one Ln(lll) ion. In one or more embodiments, the Ln(lll) complexes include two of the same Ln(lll) ion. In one or more embodiments, the Ln(lll) complexes include two different Ln(lll) ions. In one or more embodiments, the Ln(lll) complexes include more than two Ln(lll) ions. For example, the Ln(lll) complexes include three or more Ln(lll) ions.PATENTAttorney Docket No.: TXTU / 0012PC
[0039] The Ln(lll) of the above formulas (e.g., Ln) includes lanthanum (La), cerium (Ce), praseodymium (Pr), neodymium (Nd), promethium (Pm), samarium (Sm), europium (Eu), gadolinium (Gd), terbium (Tb), dysprosium (Dy), holmium (Ho), erbium (Er), thulium (Tm), ytterbium (Yb), lutetium (Lu), or combinations thereof. The ligand (e.g., L1, L2, L3, etc.) refers to a molecule capable of coordinating to one or more metal ions (e.g, Ln(lll)) through one or more electron-donating atoms to form the Ln(lll) complex. The ligand includes a multidentate structure including one or more aromatic or heteroaromatic backbones and functional groups, including but not limited to naphthalene-based ligands, pyridine-based ligands, pyrazine-based ligands, imidazole- or imidazolium-functionalized ligands, benzenetriol-based ligands, and derivatives thereof, including sulfonated, phosphonated, phosphoester, cyano¬ substituted, or bridged variants. For example, as disclosed herein, the ligand includes naphthylsalophen ligands, sulfonated naphthylsalophen ligands, pyridine-based naphthylsalophen ligands, pyrazine-based ligands, imidazolium-functionalized ligands, and benzenetriol-based ligands. The Ln(lll) complexes are synthesized using conventional chemical methods, as described below.Imidazolium-based and Benzenetriol-based Ln(lll) Complexes
[0040] For example, as shown in Figures 1A, 1B, and 1C, water-soluble imidazolium-based and benzenetriol-based ligands and their 3:2 ligand-to-lanthanide sandwich-type complexes, [Ln2(L1)3H2O], [Ln2(L2)3H2O], and [Ln2(L3)3H2O] are shown to indicate the varying Lxstructures. The Ln(lll) complexes are water-soluble at about 10mg per mL. In one or more embodiments, the Ln includes Er(III), Lu (III), Yb (III), Gb (III), Tb (III), or combinations thereof. In one or more embodiments, the ligands include imidazolium-based ligands including Schiff base products of imidazole¬ substituted aldehydes and diamines, and benzenetriol-based ligands comprising tri¬ hydroxylated aromatic coordination frameworks, each configured to coordinate one or more Ln(lll) ions to form the disclosed complexes. In one or more embodiments, the Ln(lll) complex includes a composition with the Formula (II):PATENTAttorney Docket
[0041] where Ln is one or more of the Ln(III) ion as described above.
[0042] In one or more embodiments, the Ln(lll) complex includes a composition with the Formula (III):PATENTAttorney Docket No.: TXTU / 0012PC
[0043] where Ln is one or more of the Ln(III) ion as described above.
[0044] In one or more embodiments, the Ln(lll) complex includes a composition with the Formula (IV):
[0045] where Ln is one or more of the Ln(lll) ion as described above.
[0046] In one example, upon 980-nanometer (nm) excitation, the Er(lll) example complexes exhibit metal-centered up-conversion (UC) emission in the solid state and in aqueous solution. When incubated in human cervical carcinoma cell line (HeLa) cells, the complexes seemed to localize in the mitochondria, and red and green Er-centered up-conversion emission was observed.Pyridine-based and Pyrazine-based Naphthylsalophen Ln(III) Complexes
[0047] Figure 2 illustrates pyridine and pyrazine-based naphthylsalophen ligands and their 3:2 ligand-to-lanthanide sandwich-type Ln(lll) complexes. The disclosed pyridine and pyrazine-based naphthylsalophen Ln(III) complexes are operable to bePATENTAttorney Docket No.: TXTU / 0012PCisolated and disclosed herein. The presence of a pyridyl and / or pyrazine backbone in the Ln(lll) complexes enables examination of the effect of an electron-withdrawing nitrogen (N) center on the coordination core, metal complexation, and UC efficiencies without affecting iT-stacking effects.
[0048] The general formula associated with these 3:2 ligand-to-lanthanide sandwich-type metal complexes is Equation (I), where Ln is Er(l 11), Gd(lll), and Yb(lll) and x is 1-3 or mixed metal Ln(lll) complexes with an example general composition of [(LnyLny)2(Lx)3] or [(LnyLnyLny)2(Lx)3], where Ln is Er, Yb, Y or combinations thereof and x is 1-3 and y is an integer. The synthesis of bimetallic pyridyl and pyrazine-based naphthylsalophen complexes and sulfonate incorporated bimetallic and mixed Er(lll), Yb(lll) and Er(lll), Yb(lll), Y(lll) complexes are disclosed herein. The sulfonate incorporated bimetallic complexes are represented by Formula (V):[Ln2(L'x)3] (V)
[0049] where L’xis a sulfonated ligand and Ln is a Ln metal described above. In one or more embodiments, the Equation (III) may include two or more Ln(lll) ions.
[0050] In one or more embodiments, the ligands included as L in the referenced general formulas of the ligand-to-lanthanide sandwich-type metal complexes include 1, T-((1E, TE)-(pyridine-2,3-diylbis(azaneylylidene))bis(methaneylylidene))bis(naphthalen-2-ol), which is represented by Formula (VI):
[0051] where R is a hydrogen (-H) or a sulfonic acid group (-NaSOs),PATENTAttorney Docket No.: TXTU / 0012PC
[0052] 1, 1 '-((1 E, 1 'E)-(pyridine-2,6-diylbis(azaneylylidene))bis(methaneylylidene))bis(naphthalen-2-ol), which is represented by Formula (VII):
[0053] where R is a -H or -NaSOs.
[0054] 1, 1 '-((1 E, 1 'E)-(pyrazine-2,3-diylbis(azaneylylidene))bis(methaneylylidene))bis(naphthalen-2-ol), which is represented by Formula (VIII):
[0055] where R is a -H or -NaSOs.
[0056] In one or more embodiments, the pyridyl naphthylsalophen Ln(lll) complexes include a composition with the formula (IX):PATENTAttorney Docket No.: TXTU / 0012PC
[0057] where Ln is one or more Ln(l 11) ion as described above and R is a -H or - NaSO3.
[0058] In one or more embodiments, the pyrazine naphthylsalophen Ln(lll) complexes include a composition with the Formula (X):PATENTAttorney Docket No.: TXTU / 0012PC
[0059] where Ln is one or more Ln(l 11) ion as described above and R is a -H or -NaSO3.
[0060] In one or more embodiments, the pyridyl naphthylsalophen Ln(lll) complexes includes a composition with the Formula (XI):PATENTAttorney Docket No.: TXTU / 0012PC
[0061] where Ln is one or more Ln(lll) ion as described above and R is a -H or NaSOs.
[0062] The pyridine and pyrazine naphthylsalophen Ln(lll) complexes are shown in Figure 2. The pyridine and pyrazine-based naphthylsalophen Ln(lll) complexes are obtained and characterized by X-ray diffraction, high resolution mass spectrometry, Fourier-Transform Infrared Spectroscopy (FT-IR), elemental analysis, and Inductively Coupled Plasma Mass Spectrometry (ICP-MS). The effect of electron-withdrawing nature of the N atoms in the diamine backbone of the metal complexes was analyzed. The photophysical properties of the metal complexes are studied in solid state. When excited at 980 nm, the complexes display metal-centered emission for Er(lll) in the red and green regions of the spectrum. When excited at 980 nm, the Er, and Y / Yb / Er complexes showed Er-centered up-conversion emission in the solid state.Multi-metallic Naphthylsalophen Sulfonate Ln(lll) Complexes
[0063] For example, a series of nine sulfonated naphthylsalophen Ln(lll) complexes containing substituted diamines are disclosed herein. Isolation of water-soluble bimetallic complexes that display UC in the solid state and in aqueous solution is achieved by adding sulfonate functional groups to the naphthyl moiety. The additionPATENTAttorney Docket No.: TXTU / 0012PCof the sulfonate functional groups on the ligand backbone is operable to affect the UC emission. The general composition for the sulfonated naphthylsalophen Ln(lll) complexes is represented by Formula (V) (e.g., the ligands associated in this embodiment are sulfonated). Further, the general composition is shown in the schematic of Figure 3. In one or more embodiments, the sulfonated naphthylsalophen Ln(lll) complex includes a composition with the Formula (XII):
[0064] where Ln is Er(lll), Yb(lll), Gd(lll), Y(lll) or Lu(lll) or combinations thereof and Ri and R2are -H, a methyl group (-CH3), a methoxy group (-OMe), a cyano group (-CN), a fluoro group (-F), a chloro group (-CI), a bromo group (-Br), -SO3H, or combinations thereof. In one or more embodiments, the mixed metal complex includes [(Er0.18Yb0.82)2(L1)3(H2O)] and [(Ero.i3Ybo.88)2(L3)3(H20)].
[0065] In one or more embodiments, the example Ln(lll) complexes [Ln2(L1)3H2O] and [Ln2(L2)3H2O] are obtained in >34% yields via reacting the ionic chain-PATENTAttorney Docket No.: TXTU / 0012PCfunctionalized diamine or 4-nitro-1,2-phenylenediamine with two equivalents of the imidazole-substituted aldehyde, followed by the addition of 2 / 3 equivalents of the desired Ln(lll) chloride hydrate and four equivalents of triethylamine in MeOH. All [Ln2(L3)3H2O] are obtained in yields above 43% by the condensation of 3,4-diaminobenzonitrile and two equivalents of 2,4, 6-tri hydroxy benzaldehyde in methanol (MeOH), triethylamine (TEA), and 2 / 3 equivalents of the desired Ln(lll) chloride hydrate. Isolation of the complexes is confirmed through1H-NMR of the analogous diamagnetic Lu(lll) complexes, ESI-TOF mass spectrometry, FT-IR, ICP-MS, and elemental analysis, and the data are consistent with a 2:3 metai-to-ligand structure, as reported for other sandwich complexes. The data for examples of the Ln(lll) complexes are disclosed below and shown in Figures 6A-23B.Materials and Methods
[0066] As disclosed herein, materials and methods are directed to preparation, characterization, and evaluation of lanthanide(III) complexes having general formulas including Ln2(Lx)3, Ln2(L'x)3, and related coordination structures. Ln includes one or more lanthanide(lll) ions and L includes a multidentate ligand. In one or more embodiments, Ln includes erbium(lll), gadolinium(lll), lutetium(lll), ytterbium(lll), yttrium(lll), or combinations thereof. In one or more embodiments, Lxincludes ligands formed from Schiff base condensation of aldehyde and diamine precursors and may include aromatic or heteroaromatic backbones with nitrogen and / or oxygen donor atoms. Exemplary ligand families include naphthalene-based ligands, pyridine-based ligands, pyrazine-based ligands, imidazole- or imidazolium-functionalized ligands, benzenetriol-based ligands, and derivatives thereof including sulfonated, cyanosubstituted, biscyano-substituted or otherwise functionalized variants. Representative complexes evaluated herein include complexes corresponding to L1, L2, and L3ligand systems and combinations thereof.Characterization
[0067] As disclosed herein, the Ln(lll) complexes were tested with a variety of chemical experiments to confirm the structure, composition, and photophysical properties of the Ln(lll) complexes (e.g., characterize the Ln(lll) complexes). ThesePATENTAttorney Docket No.: TXTU / 0012PCbelow disclosed experiments include spectroscopic, analytical, and photophysical characterization techniques commonly used to evaluate Ln(l 11) complexes.Nuclear magnetic resonance (NMR) spectroscopy
[0068] In one or more embodiments,1H-NMR was recorded on JEOL ECS 400 MHz and Broker Avance NEO 700 MHz NMR spectrometers operating at 298 K equipped with a Broker Prodigy inverse detection probe.1H-NMR spectra were referenced internally to the solvent resonances. NMR samples were dissolved in deuterated dimethyl sulfoxide (DMSO-de), deuterium oxide (D2O), and deuterated chloroform (CDCh) as noted.Electrospray ionization time-of-flight (ESI-TOF) Mass spectrometry
[0069] HRMS studies were performed for all the samples. High resolution mass spectrometer Orbitrap Fusion Lumos from Thermo Scientific, Palo Alto, CA was used at resolution of 120,000 using ESI and infusion using methanol-water solvent containing 2 millimolar (mM) of ammonium formate. Isotope pattern distribution was obtained with the instrument’s software at the same resolution. Samples were analyzed at a concentration of 1 microgram per milliliter. Traces of residual moisture from the carrier gas, solvent system, or analyte may be observed under these conditions.Fourier-transform infrared (FT-IR) spectroscopy
[0070] Infrared spectra were obtained in the solid state using an attenuated total reflectance (ATR) method on a Thermo Scientific Nicolet iS50 FT-IR instrument. Elemental Analysis
[0071] Analysis was conducted at Atlantic Microlab. Samples were washed with methanol then adhered with carbon tape to an aluminum stub followed by pressing the sample to the carbon tape. Excess powder was removed to ensure an evenly distributed powder coating.One-photonPATENTAttorney Docket No.: TXTU / 0012PC
[0072] Using solutions at 1x1 O'4molar (M) in dimethyl sulfoxide(DMSO), the photoluminescence data were obtained using a Fluorolog-3 spectrofluorometer (Horiba FL3-22-IHR550), with 1200 grooves / mm excitation monochromator gratings blazed at 330 nm and 1200 grooves / mm or 600 grooves / mm emission monochromator gratings blazed at 500 nm or 1000 nm for ultraviolet-visible (UV-Vis) or NIR range, respectively. A 450 W ozone-free xenon lamp (Ushio) was used as the radiation source. The excitation spectra, corrected for instrumental function, were measured between about 250 nm to about 600 nm. The emission spectra, corrected for instrumental function, were measured in the range 1400-1600 nm using a Hamamatsu 5509-73 detector cooled with liquid N2. Fluorescence and phosphorescence spectra were acquired at 77 K on a Perkin Elmer LS-55 using Gd(lll) complexes in dimethyl sulfoxide (DMSO). Scan rate was 250 nm / s, filters were applied to cut off scattering from the excitation beam as appropriate, and excitation and emission slit widths for the individual measurements are indicated below. The spectra were deconvoluted into their Franck-Condon progression, and the singlet and triplet energies are reported as the 0-0 transition.Up-conversion, two-photon
[0073] The complex up-conversion emission data were obtained using a Fluorolog-3 spectrofluorometer (Horiba FL3-22-iHR550), with 1200 grooves / mm emission monochromator with gratings blazed at 500 nm in the about 510 nm to about 700 nm range using a Hamamatsu 928P detector. All emission spectra were corrected for instrumental function. The emission was collected in the solid state, and all samples were dried under reduced pressure at 40 °C overnight before being used. The excitation source was a 980 nm laser operating in continuous wave mode (beam diameter 5 x 8 mm2, Opto Engine MDL-lll-980nm-2.5W). Integration times were 20-40 seconds, and the slit width was 9 nm. The emission decay curves were obtained using a Time-Correlated Single Photon Counting (TCSPC) system and an MLL-III-980 / 1-2500 mW infrared diode laser (peak wavelength ~ 980 ± 10 nm) as excitation source on the Fluorolog-3 fluorimeter.X-ray DiffractionPATENTAttorney Docket No.: TXTU / 0012PC
[0074] Crystals suitable for single crystal X-ray diffraction (XRD) were selected and mounted on a 50-micron MiTeGen loop using Paratone-N oil and data set collection was completed on a Broker D8 VENTURE K-geometry diffractometer using Cu-Ka radiation (Incoatec IpS DIAMOND microfocus sealed tube (A = 1.54178 A). Crystals were kept at 100 K during unit cell and data collection. Determination of the unit cell and collection of data were performed using the APEX III software, and determination of integrated intensities and global cell refinement were performed with the Bruker SAINT software package. An empirical absorption correction (SADABS) was applied. Structures were solved using Intrinsic Phasing / Direct Methods.3, 4 (SheIXT) and least- squares refinement was performed using ShelXL in APEX III. Projections were created on Olex2.1.Powder X-ray Diffraction (PXRD)
[0075] PXRD patterns of the powders were obtained using a Bruker D8 diffractometer. The measurements were conducted with Bragg-Brentano geometry 89 Experimental Section Materials and Equipment and Cu-Ka radiation. The measurements were performed within the range of 0 to 50 degrees.Biological Experiments
[0076] As disclosed herein, the Ln(lll) complexes were tested with a variety of biological experiments to evaluate biocompatibility, cellular uptake, and imaging performance of the Ln(lll) complexes. These below disclosed experiments include cell-based assays and imaging techniques commonly used to assess suitability of compounds for biological and bioimaging applications.Ceil culture
[0077] The HeLa cell line was cultured in Roswell Park Memorial Institute (RPMI) 1640 medium (Gibco) supplemented with 10% fetal bovine serum, penicillin (100 U mL-1), streptomycin (100 pg mL-1) and glutamine. The cells were incubated at 37 °C and 5% CO2.Cell viability assayPATENTAttorney Docket No.: TXTU / 0012PC
[0078] The viability of HeLa cells incubated with [Er2(L1)3H2O], [Er2(L2)3H2O], and [Er2(L3)3H2O] was determined with methyl thiazolyltetrazolium (MTT) assays. HeLa cells were seeded into 96 well plates (105 cells / mL) and incubated for 24 h prior to beginning the experiment. Aqueous solutions of each complex, [Er2(L1)3H2O], [Er2(L2)3H2O], or [Er2(L3)3H2O], in phosphate-buffered saline (PBS) buffer were added into the wells at varying concentrations (e.g., about 10 pM to about 100.0 pM) and incubated for about 4 hours. The solution was removed, and the cells were washed with PBS buffer. New cell culture medium was added and incubated overnight for about 18 hours. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide solution was added to each well and incubated for about 3 hours. The supernatant liquid was removed and 100 pl of spectroscopic grade DMSO was added into each well to dissolve the formazan crystals produced by the remaining live cells. The absorbance at 540 nm was acquired using a Spectramax M3 plate reader (Molecular Devices).
[0079] Cell viability was calculated using formula (XIII):
[0080] Ac and AB are the absorbance of the negative control (cells + MTT + DMSO) and blank (DMSO), respectively.Bioimaging experiments
[0081] HeLa cells were seeded into a glass three-chamber microscope slide (1x105cells / ml) with cell culture media (200 pl) and incubated for 2 days. Stock solutions of Hoechst 33342 (Millipore Sigma) and Mitotracker Green FM (Invitrogen) were prepared according to the manufacturer. The cells were incubated with [Er2(L1)3H2O], [Er2(L2)3H2O], or [Er2(L3)3H2O] in a 1:1 ratio of sterile water and cell culture media at a concentration of 10 mM for 4 hrs. Then, they were washed with PBS buffer (2x) to remove excess dye and used for imaging. In a separate set of HeLa cells, the cells were incubated with Mitotracker Green FM (10 mM in 1:1 PBS buffer: cell culture media) for 0.5 hr and washed with PBS buffer (2x) to remove excess dye. Finally, both sets of cells were incubated with Hoechst 33342 (1 pg / 1 mL in 1:1 PBS buffercell culture media) for 10 minutes and washed with PBS buffer (2x) toPATENTAttorney Docket No.: TXTU / 0012PCremove excess dye. Excess liquid was removed, and the slides were covered with cover slip and imaged immediately.
[0082] A Leica SP8 scanning upright confocal microscope was used to collect live¬ cell images of HeLa cells by simultaneous collection of 3 detection channels (two photomultiplier tubes (PMTs), one hybrid detector (HyD)) using multiple laser lines (405 nm, 488 nm) and a 40x objective. The confocal microscope is configured with a conventional tandem scanner (8 kHz), a super Z-galvo stage type S, and stands on an anti-vibration table. The confocal is connected to a workstation with Leica LAS-X software and with a resolution down to 120 nm. Emission from the Hoechst 33342 dye was collected using the 405 nm laser line and collected on a PMT between about 415 nm to about 480 nm. Emission from the Mitotracker Green PM dye was collected using the 488 nm laser line and collected on a PMT between about 500 to about 560 nm. Ligand emission of the Ln(lll) metal complexes was collected using the 488 nm laser line and collected on a PMT between about 500 nm to about 560 nm. Images were collected at room temperature as 1024 x 1024-pixel images. Microscope and camera settings were kept constant, and care was taken to avoid potential crosstalk.
[0083] 2-Photon imaging was taken on a Leica Stellaris DIVE Multiphoton Microscope an upright Dm6 microscope configured with a conventional tandem scanner (8 kHz), a VarioBeam Expander, and equipped with a Coherent Chameleon Vision II multiphoton laser (600-1080 nm) and 4 standard laser lines (405, 488, 561, 638 nm). Long working distance objectives include 10x, NA 0.4, HC PL APO CS2 (Air), 20x, NA 0.75, HC PL APO CS2 (Air), 10x, NA 0.3, HC APO W U-V-l (Water), 25x, NA 0.95, HC FLUOTAR WVISIR (Water).Photophysical Characterization
[0084] All photophysical measurements are the average of at least three independent measurements, and, unless otherwise indicated, performed at 25.0 ± 0.1 °C.One-photonPATENTAttorney Docket No.: TXTU / 0012PC
[0085] Solutions of the Ln(lll) metal complexes were [1x1 O'5M] in DMSO. The photoluminescence data were obtained using a Fluorolog-3 spectrofluorometer (Horiba FL3-22-IHR550), with 1200 grooves / mm excitation monochromator gratings blazed at 330 nm and 1200 grooves / mm or 600 grooves / mm emission monochromator gratings blazed at 500 nm or 1000 nm for UV-Vis or NIR range, respectively. A 450 W ozone-free xenon lamp (Ushio) was used as the radiation source. The excitation spectra, corrected for instrumental function, were measured between 250 and 600 nm. The emission spectra, corrected for instrumental function, were measured in the range 1400 nm to 1600 nm using a Hamamatsu 5509-73 detector cooled with liquid N2. Fluorescence and phosphorescence spectra were acquired at 77 K on a Perkin Elmer LS-55 using Gd(lll) complexes. Scan rate was 250 nm / s, filters were applied to cut off scattering from the excitation beam as appropriate, and excitation and emission slit widths for the individual measurements are indicated below. The spectra were deconvoluted into their Franck-Condon progression, and the singlet and triplet energies are reported as the 0-0 transition. Up-conversion, two-photon
[0086] The complex up-conversion emission data were obtained using a Fluorolog-3 spectrofluorometer (Horiba FL3-22-IHR550), with 1200 grooves / mm emission monochromator with gratings blazed at 500 nm in the 510-700 nm range using a Hamamatsu 928P detector. All emission spectra were corrected for instrumental function. The emission was collected in the solid state, and all samples were dried under reduced pressure at 40 °C overnight before being used. The excitation source was a 980 nm laser operating in continuous wave mode (beam diameter 5 x 8 mm2, Opto Engine MDL-lll-980nm-2.5W). Integration times were 20-40 seconds, and the slit width was 9 nm.Quantum yield.
[0087] Standards used for emission quantum yield measurements [Yb(tta)3(H2O)2] in toluene ( = 12%).2The quantum yield of the samples was determined by the dilution method using the following Formula (XIV). The excitation wavelength for the samples and standard was 370 nm.PATENTAttorney Docket No.: TXTU / 0012PC
[0088] Grad is the slope of the plot of the integrated emission as a function of absorbance, n is the refractive index of the solvent, I is the intensity of the excitation source at the excitation wavelength and is the quantum yield for sample (x) and standard (std).
[0089] Coordinated MeOH molecules. The emission lifetimes in MeOH and MeOD were used to determine the number of coordinated solvent molecules q using equation (XV).Synthesis Methods and ResultsImidazolium and Benzenetriol Based Lnflll) Complexes ([LmfL HiO]) Examples
[0090] Unless specified, all reactions were open to atmosphere without any special conditions. The solvents MeOH (Fischer), hexane (Sigma), acetonitrile (Fischer) were purchased as ACS grade and used as received without further purification. The reagents 2-hydroxy-1 -naphthaldehyde (AmBeed), 3,4-diaminobenzonitrile (AmBeed), triethylamine (Sigma), choline chloride (Sigma), 1-methyl imidazole (Sigma), formaldehyde solution 37 wt% (Sigma), salicylaldehyde (Sigma), 4-nitrobenzene-1,2- diamine (Sigma), 2,4,6-trihydroxybenzaldehyde (Sigma), erbium(lll) chloride hydrate (99.9%, STREM), gadolinium (111 ) chloride hydrate (99.9%, STREM), lutetium(l 11) chloride hexahydrate (99.9%, Sigma) were used without further purification.Synthesis of imidazole substituted aldehyde
[0091] Figure 5A shows a schematic representation of a synthesis of imidazole substituted aldehyde, which is later used in the synthesis of the disclosed Ln(lll) complexes. In one or more embodiments, the imidazole substituted aldehyde is a portion of the ligand. In one or more embodiments, a mixture of salicylaldehyde (17.79 mL, 0.170 mmol), formaldehyde 37 wt. % in H2O (18.89 mL, 0.255 mmol), andPATENTAttorney Docket No.: TXTU / 0012PCconcentrated hydrochloric acid (150 mL) was stirred for 24 hours to form a solid. The resulting solid was filtered and washed with 10% potassium carbonate (K2CO3) solution, recrystallized with hexanes to obtain white crystalline precipitates of chloromethylated aldehyde (0.866 g, 50%). The chloromethylated aldehyde (3.629 g, 0.213 mmol) was dissolved in acetonitrile (25 mL) under argon atmosphere. 1-methylimidazole (3.39 mL, 0.425 mmol) was then added slowly to the above solution which was stirred for 3 hours at room temperature to form a solid. The resulting solid was washed with acetonitrile to obtain a light-yellow product (4.053 g, 71%). FT-IR (v, cm1) 3039, 2867 (C-H); 1671 (C=N); 1611 (OC); 1254 (C-O); 1151 (ON).Synthesis of ionic chain functionalized diamine
[0092] Figure 5B shows a schematic representation of a synthesis of ionic chain functionalized diamine, which is later used in the synthesis of the disciosed Ln(III) complexes. In one or more embodiments, the ionic chain functionalized diamine is at least a portion of the ligand. In one or more embodiments, using the principles of mechanochemistry, 3,4-diaminobenzoic acid (0.552 g, 0.363 mmol) and choline chloride (0.526g, 0.376 mmol) were mixed using glass balls in a mechanical stir plate for 30 minutes at 1200 rpm to form a solid. The resulting solid was dried in vacuum for 12 hours to obtain a light brown substituted diamine product (0.733 g, 74%). Synthesis of the ionic chain functionalized diamine was characterized with the following results:1H NMR (400 MHz, DMSO-d6) 67.13 (d, H, J = 2.2 Hz), 7.06 (dd, H, J = 8.3 Hz, 8.2 Hz), 6.48 (d, H, J = 7.1Hz), 5.44 (s, 4H), 3.84 (t, 2H, J = 5.2 Hz), 3.81 (t, 2H, J = 5.1 Hz), 3.11 (s, 9H). TOF MS (ESI) m / z [M+H]1+C12H25N3O2 (Calc.) 243.1837, (Found) 243.1841. FT-IR (v, cm'1) 3292, 3166 (N-H); 1620 (C=C); 1475 (C=O); 1318 (C-O); 1084 (C-N+).Synthesis of Imidazolium and Benzenetriol Based Ln(III) Complexes with the [Ln2(Lx)3HzO] Formula
[0093] Figures 1A, 1B, and 1C illustrate a representation of the ligand structures and the corresponding imidazolium-based and benzenetriol-based Ln(lll) complexes described herein. The illustrated structures include multidentate ligands comprising aromatic and heteroaromatic backbones with electron-withdrawing atoms, such as nitrogen and oxygen, as well as Ln(lll) complexes formed from coordination of thePATENTAttorney Docket No.: TXTU / 0012PCdisclosed ligand structures to Ln(lll). The ligands and Ln(lll) complexes further include functional groups, including charged imidazoiium substituents, electron¬ withdrawing groups such as nitro substituents, and hydrophilic groups such as hydroxyl and cyano substituents, which provide tunable electronic properties and solubility characteristics. The depicted structures demonstrate formation of Ln(lll) complexes from the corresponding ligands, including Ln(lll) complexes having the general formula Ln2(L)3, where Ln is a lanthanide ion and L is a ligand. The below shows exemplary data for specific tested examples of the Ln(lll) complexes disclosed herein.Example 1: Synthesis of [L^L^st- O], Formula (II)
[0094] The substituted phenylene diamine (0.100 g, 0.370 mmol), imidazole substituted aldehyde (0.197 g, 0.730 mmol), and TEA (206 pL, 1.480 mmol) were dissolved In 10 mL MeOH. The Ln(lll) chloride (Ln(lll) = Er(lll), Gd(lll), Lu(lll)) hydrate (0.246 mmol) was dissolved in MeOH and added to the solution, which was refluxed for 24 hours at 40°C. The solvent was removed under reduced pressure to obtain a solid. The resulting solid was washed with methanol and dried in vacuum for an hour to yield the metal complex. For example, Figure 1A, shows a schematic representation of forming the composition of Formula (II). The below characterization results identify which Ln metal ion was incorporated into Formula (II) within the Equation (I) format. Example 1 yields a Ln(lll) complex using the ligand L1.
[0095] In one or more embodiments, the synthesis yields: Er2(L1)3: 0.132 g, 48%, Gd2(L1)3; 0.101 g, 37 %, Lu2(L1)3: 0.143 g, 52 %, or combinations thereof. Example 1 was characterized with the following results: Figure 6A shows the1H NMR of [Lu2(L1)3H2O] (D2O, 700MHz, 298K). Lu2(L')3-1H-NMR (700 MHz, D2O, 298K) 68.46 (s, 12H), 8.24 (s, 3H), 7.89 (d, 6H, J = 7.6 Hz), 7.80 (d, 9H, J = 7.5 Hz), 7.46 (d, 3H, J = 1.6 Hz ), 7.40-7.35 (m, 6H), 6.82 (s, 3H), 6.22 (s, 6H), 3.23-3.21 (m, 6H), 3.21-3.20 (m, 6H), 3.07 (d, 6H, J = 7.6 Hz), 2.88 (s, 9H), 2.83 (d, 6H, J = 1.1 Hz), 2.77 (s, 9H), 2.60 (s, 27 H). ). LU2(L1)3-TOF MS (ESi) m / z [M+2H]2+forCio8Hi24N2iOi3Cl8Lu2 (Calc) 1278.3643 g, (Found) 1278.3649 g.PATENTAttorney Docket No.: TXTU / 0012PC
[0096] Figure 6E shows the isotope distribution pattern (z= 2) of [Lu2(L1)3H2O] (top: experimental; bottom: caiculated). Figure 6B shows the Er2(L1)3-FT-IR (v, cm’1) 3850, 2989 (C-H); 3312, 3069 (N-H); 1609 (C=N); 1266 (C-O); 1080 (C-N+). Er2(Li)3-TOF MS (ESI) m / z [M+2H]2+for Cio8Hi2oN2iOi2Cl9Er2(Calc) 1278.3562 g, (Found) 1278.3560 g. Er2(L1)3-Elemental analysis for Cio8Hi22N2iOi3Cl9Er2(Calc. %) C, 51.20; H, 4.75; N, 9.96 (Found %): C, 51.17; H, 4.38; N, 9.65. Figure 6C shows isotope distribution pattern (z= 2) of [Er2(L1)3H2O] (top: experimental; bottom: calculated).
[0097] Gd2(L')3-TOF MS (ESI) m / z [M+2H]2+for Cio8Hio8N2iOi4CI9Gd2(Calc.) 1278.3651 g, (Found) 1278.3651 g. Gd2(L1)3- Elemental analysis for Cio2Hio4Ni8Oi3Cl9Gd2-6H20(Calc. %) C, 48.39; H, 4.61; N, 9.90 (Found %): C, 48.38; H, 4.66; N, 9.59. Figure 6D shows the isotope distribution pattern (z= 2) of [Gd2(L1)3H2O] (top: experimental; bottom: calculated).Example 2: Synthesis of [Ln2(L2)3H2O] Formula (III)
[0098] 4-Nitro-1,2-phenylene diamine (0.0286 g, 0.187 mmol) and imidazole substituted aldehyde (0.100 g, 0.370 mmol) were dissolved in 10 ml_ MeOH. The Ln(lll) chloride (Ln(lll) = Er(lll), Gd(lll), Lu(lll)) hydrate (0.125 mmol) was dissolved in MeOH and added to the solution, which was refluxed for 24 hours at 40°C. The resulting solid was washed with methanol and dried in vacuum for an hour to yield the metal complex. For example, Figure 1B shows the schematic representations of forming the composition of Formula (III). The below characterization results identify which Ln metal ion was incorporated into Formula (III) within the Formula (I) format. Example 2 yields a Ln(lll) complex using the ligand L2.
[0099] In one or more embodiments, the synthesis yields: Er2(L2)3: 0.038 g, 60 %, Gd2(L2)3: 0.025 g, 34 %, Lu2(L2)3: 0.036 g, 53 %, or combinations thereof. Example 2 was characterized with the following results: Figure 7 A showsNMR of [Lu2(L2)3H2O] (DMSO-de, 700MHz, 298K). Lu2(L2)3-1H-NMR (700 MHz, DMSO-d6, 298K) 6 12.46 (s, 12H), 11.17 (s, 3H), 10.98 (d, 6H, J = 13.1 Hz), 10.59 (d, 6H, J = 12.2 Hz), 10.29-10.27 (m, 9H), 10.20 (s, 3H), 8.54-8.49 (m, 6H), 8.33 (s, 6H), 7.87 (s, 6H), 7.18 (s, 6H), 3.86 (s, 9H), 3.82 (s, 9H). Lu2(L2)3-TOF MS (ESI) m / z [M+2H]2+for C9oH78N2iOi3Cl6Lu2.2H20 (Calc) 1130.3251 g, (Found) 1130.3254 g. Figure 7DPATENTAttorney Docket No.: TXTU / 0012PCshows the isotope distribution pattern (z= 2) of [Lu2(L2)3H2O] (top: experimental; bottom: calculated).
[0100] Figure 7B shows the IR spectrum of [Er2(L2)3H2O]. Er2(L2)3- FT-IR (v, cm'1) 1619 (C=N); 1557, 1370 (N-O): 1163 (C-N+); 1288 (C-O). Er2(L2)3-TOF MS (ESI) m / z [M+2H]2+for C9oH78N2iOi2Cl4Er2(Calc.) 1060.2565 g (Found) 1060.2563 g. Er2(L2)3-Elemental analysis for C 7H62Ni8Oi3Cl6Er2-8H2O (Calc. %) C, 43.24; H, 3.74; N, 11.74 (Found %): C, 43.08; H, 3.97; N, 11.66. Figure 7C shows the isotope distribution pattern (z= 2) of [Er2(L2)3H2O] (top: experimental; bottom: calculated).
[0101] Gd2(L2)3-TOF MS (ESI) m / z [M+2H]2+for C9oH79N2iOi3Cl4Gd2(Calc.) 1059.2617 g (Found) 1059.2617 g. Gd2(L2)3- Elemental analysis for CS8H6oNisOi3CI6Gd2.6H20(Calc. %) C, 41.99; H, 3.73; N, 11.52 (Found %): C, 41.90; H, 3.73; N, 11.21. Figure 7E shows the isotope distribution pattern (z= 2) of [Gd2(L2)3H2O] (top: experimental; bottom: calculated).Example 3: Synthesis of [Ln2(L3)3H2O] Formula (IV)
[0102] 3,4-Diaminobenzonitrile (0.100 g, 0.751 mmol), 2,4,6-trihydroxy benzaldehyde (0.231 g, 1.502 mmol), and TEA (418 pL, 3.00 mmol) were dissolved in 10 ml_ MeOH. The Ln(ll l)chloride (Ln(lll) = Er(lll), Gd(lll), Lu(lll)) hydrate (0.500 mmol) was dissolved in MeOH and added to the solution, which was refluxed for 24 hours at 40°C. The solvent was removed under reduced pressure using a rotary evaporator to obtain a solid. The resulting solid was washed with methanol and dried in vacuum for an hour to yield the metal complex. For example, Figure 1C shows s schematic representation of forming the composition of Formula (IV). The below characterization results identify which Ln metal ion was incorporated into Formula (IV) within the Equation (I) format. Example 3 yields a Ln(lll) complex using the ligand L3.
[0103] In one or more embodiments, the synthesis yields: Er2(L3)3: 0.418 g, 54 %, Gd2(L3)3: 0.319 g, 43 %, Lu2(L3)3: 0.346 g, 44 %, or combinations thereof.
[0104] Example 3 was characterized with the following results: Figure 8A shows1H NMR of Lu2(L3)3-1H-NMR (700 MHz, DMSO-d6) 69.93 (s, 12H), 8.47 (s, 6H), 6.53 (s, 3H), 5.93 (s, 3H), 5.84 (s, 3H), 5.79 (s, 3H), 5.66 (s, 3H), 5.54 (s, 3H), 4.85 (s, 3H),PATENTAttorney Docket No.: TXTU / 0012PC4.35 (s, 3H). Lu2(L3)3-TOF MS (ESI) m / z [M+H]1+forC63H38N9Oi9Lu2(Calc) 1574.4281 g, (Found) 1574.4286 g. Figure 8C shows the isotope distribution pattern (z= 2) of [Lu2(L3)3H2O] (top: experimental; bottom: calculated).
[0105] Figure 8B shows the IR spectrum of [Er2(L3)3H2O], Er2(L3)3- FT-IR (v, cm-1) 3057 (O-H); 2219 (C=N); 1536 (C=N); 1262 (C-O). Er2(L3)3-TOF MS (ESI) m / z [M+2H]2+for C63H3sN9Oi9Er2 (Calc.) 779.1532 g, (Found) 779.1533 g. Er2(L3)3-Elemental analysis for CssH^NeOwEmSI-W (Calc. %) C, 42.19; H, 3.54; N, 5.57 (Found %): C, 42.21; H, 3.73; N, 5.35. Figure 8D shows the isotope distribution pattern z~ 2) of [Er2(L3)3H2O] (top: experimental; bottom: calculated).
[0106] Gd2(L3)3-TOF MS (ESI) m / z [M+2H]2+for CssH^NgOisGd; (Calc.) 764.5811 g, (Found) 764.5815 g. Gd2(L3)3- Elemental analysis for O63H45N9Oi9Gd2-8H2O(Calc. %) C, 43.20; H, 3.62; N, 6.23 (Found %): C, 43.28; H, 3.72; N, 6.26. Figure 8E shows the isotope distribution pattern z= 2) of [Gd2(L3)3H2O] (top: experimental; bottom: calculated).Photophysical Characterization of Imidazolium and Benzenethiol Based Ln(lll) Complexes
[0107] In one or more embodiments, fluorescence and phosphorescence spectroscopy of the Gd(lll) analogs indicates that the excited singlet energy levels are between 22,900 and 27,670 cm-1and triplet energy levels of the ligands are between 20,310 and 22,710 cm-1, as shown in Table 1.Table 1aDetermined from the fluorescence and phosphorescence spectra at 77 K after deconvolution and indicated as the zero-phonon band.
[0108] Table 1 shows the singlet (1S) and the triplet (3T) state energies of the Ln (III) complexes tested in dimethyl sulfoxide (DMSO). The values in Table 1 werePATENTAttorney Docket No.: TXTU / 0012PCdetermined from deconvolution of the fluorescence (1S) and phosphorescence (3T) spectra at 77 K and indicated as the zero-phonon band. The values in Table 1 are consistent with those conventionally reported for Ln(lll) complexes with similar structures (e.g., the molecular examples discussed above). While the triplet energy levels are considerably higher than the emissive state of Er(lll) (-10,000 cm-1), weak Er(lll)-centered NIR emission at 1540 nm (4hs / 24hs / 2) are observed for all three Ln(lll) complexes in DMSO solution. The absorption spectra of [Er2(L1)3H2O], [Er2(L2)sH2O], and [Er2(L3)3H2O] displayed broad peaks with maxima at 342, 362, and 383 nm, respectively, which resemble the excitation spectra, consistent with sensitization through the ligand. In addition to ligand-sensitized emission, the postulated 2:3 structure of the disclosed Ln(l 11) complexes places the Ln(lll) ions within Forster distance of each other, indicating that they are good candidates for UC luminescence.
[0109] In one or more embodiments, as shown in Figure 9A and Figure 9B, all three Er(lll) complexes showed UC-sensitized emission in the solid state when excited at 980 nm. Figure 9A shows the solid-state UC emission spectra of [Er2(L’)3H2O] using variable laser power. Figure 9B shows the logarithmic plot of the emission intensity of the transitions2H 11 / 2 ->4lis / 2 (squares),4Ss / 2 ->4hs / 2 (circles), and4F9 / 2 -4li5 / 2 (triangles) as a function of the laser power P. Xexc = 980 nm, P -0.593-2.500 W, integration time 20 seconds. Figure 9B further indicates that the emission spectra show three emission bands in the green and red region of the spectrum corresponding to the Er(lll)-centered transitions2Hi 1 / 2 >4lis / z,4Ss / 24ll5 / 2, and4F9 / 24ll5 / 2.
[0110] Table 2 shows lifetimes (T) of the4Ss / 2 excited state in the solid state. As shown in Table 2, the microsecond lifetimes of the4Ss / 2 excited state are similar to conventional reports in other UC systems based on Yb(lll) / Er(lll) nanoparticles, Er(lll) doped micro- and nano-crystals, Er(lll)-doped niobium oxide nanoparticles, and Er(lll) complexes. While [Er2(L1)3H2O] and [Er2(L2)sH2O] have similar lifetimes, [Er2(L3)3H2O] is vastly shorter.Table 2PATENTAttorney Docket No.: TXTU / 0012PCaDetermined from the4S3 / 2 -4115 / 2 transition ( exc = 980 nm).
[0011] The quenching of the Er(ll!) excited states is attributed to the increase in -OH vibrations from the ligand.
[0012] Figure 10 shows pictures of the UC emission from [Er2(L1)3H2O] solid state samples, Xexc = 980 nm, P = 2.500 W. [Er2(L1)3H2O] displayed the highest emission intensity, and [Er2(L')3H2O] emission is seen with the naked eye, as shown in Figure 9. The almost quadratic dependence of the emission intensity (I) on the laser power (P), as shown in Figure 9B, confirms the 2-photon nature of the process. The slopes are non-integer, which is attributed to the low molar absorption coefficient of Er(lll), and nonradiative decay in the emissive levels. UC emission is observed with power densities as low as 1.48 W / cm2.
[0113] In one or more embodiments, the UC-sensitized emission in both water and D2O solutions for [Er2(L1)3H2O] shows the expected Er(l I l)-centered transitions:2Hu / 2-->4li5 / 24S3 / 2 -->4115 / 2, and4Fg / 2-->4li5 / 2, which are shown in Figure 11. Figure 11 shows the up-conversion spectra of [Er2(L1)3H2O] in H2O and D2O. [complex] = 7.02 x 10-5M, exc = 980 nm, slit width = 9 nm, integration time: 20s. As a comparison, in the solid state, the intensity of the4S3 / 24hs / 2 transition is about 110-fold more intense than in solution, as would be expected due to quenching of the excited states by solventbased OH vibrations. Emission in D2O is more intense than in H2O. The UC emission for [Er2(L2)3H2O] and [Er2(L3)3H2O] was weaker in the solid state than for [Er2(L1)3H2O].Cell Viability Studies of Imidazolium and Benzenethiol Based Ln(lll) Complexes
[0114] To assess the compatibility of the Ln(lll) complexes with biological media for bioimaging applications, the cell viability of HeLa cells when incubated with [Er2(L1)3H2O], [Er2(L2)3H2O], or [Er2(L3)3H2O] was studied using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay (MTT) assay. Figure 12 shows the viability of HeLa cells when the HeLa cells are incubated with [Er2(L1)3H2O],PATENTAttorney Docket No.: TXTU / 0012PC[Er2(L2)3H2O], or [Er2(L3)3H2O] as a function of compound concentration. At concentrations below 40 pM, the Ln(lll) complexes showed a cell viability of at least about 85 %.
[0115] The HeLa cells are incubated with 10 micromolar (pM) solutions of the Ln(lll) complexes and Hoechst 33342 dye. The ligand-based luminescence is observed in the cytoplasm, while the dye stained the nuclei. Additional co-localization studies with Mitotracker Green indicate that the Ln(lll) complexes localize in the mitochondria, as shown in Figure 13. Figure 13 shows the confocal fluorescence images of HeLa cells incubated with [Er2(L1)sH2O] and Hoechst 33342 dye (top row) and additional Mitotracker Green (bottom row), [complex] - 10 pM, Xexc - 488 nm, [Hoechst 33342] = 10 pM, Aexc= 402 nm. [Mitotracker Green] = 10 pM, exc = 488 nm.
[0016] Even though [Er2(L2)sH2O] and [Er2(L3)3H2O] exhibited no UC emission in aqueous solution at the highest power density (6.25 W / cm2), [Er2 L2)3H2O and [Er2(L3)3H2O] are included with [Er2(L1)sH2O] to study UC emission in HeLa cells as the 2-photon microscope is equipped with a laser operable to show the UC emission. Under 2-photon excitation at 980 nm, both red and green UC emission is observed for Ln(lll) complexes, as shown in Figure 14. [Er2(L1)sH2O] exhibited the strongest emission and [Er2(L3)3H2O] the weakest, consistent with what was observed in the solid state. HeLa cells without the Ln(lll) complexes exhibited no emission when irradiated at 980 nm. The analogous Gd(lll) did not show emission, confirming that the signals observed in the 2-photon microscope for the Er(lll) complexes are due to Er(lll)-centered UC emission.
[0117] As described above, three Er(lll) complexes that exhibited red, green, and blue up-conversion emission upon excitation at 980 nm with power densities as low as 1.48 W / cm2are disclosed. [Er2(L1)3H2O] exhibited the most intense up-conversion emission in solid-state and also exhibited up-conversion emission in aqueous solution. All three Ln(lll) complexes are biocompatible with HeLa cells at concentrations less than 40 pM, were shown to localize in the mitochondria; and all showed UC emission in the cells. The Ln(lll) complexes disclosed herein show that up-conversion emission in aqueous solution fromPATENTAttorney Docket No.: TXTU / 0012PCEr(lll)-based complexes are operable to be used to image cells in two-photon experiments and, thus, have potential for bioimaging applications.Pyridyl and Pyrasal Naphthylsalophen Lnflll) complexes [Lm (Lx)3] Examples
[0118] All reactions were open to atmosphere without any special conditions. The solvents methanol (MeOH) (Fisher), ethanol (Sigma), dichloromethane (DCM) (Sigma), chloroform (Fisher), hexanes (Sigma), were purchased as American Chemical Society (ACS) grade and used as received without further purification. The reagents 2-hydroxy-1 -naphthaldehyde (AmBeed), sulfuric acid (Sigma), sodium chloride (Fisher), 2,3-diaminopyridine (AmBeed), 2,6-diaminopyridine (Sigma), 2,3-diaminopyrazine (AmBeed), triethylamine (Sigma), erbium (III) chloride hydrate (99.9%, STREM), ytterbium(l 11) chloride hydrate (99.9%, STREM), yttrium(lll) chloride hydrate (99.9%, STREM), gadolinium(ll I) chloride hydrate (99.9%, STREM), lutetium(lll) chloride hexahydrate (99.9%, Sigma) were used without further purification.
[0119] As disclosed below, the isolated pyridyl and pyrasal naphthylsalophen Ln(lll) complexes and mixed Ln(lll) metal complexes containing Er / Yb and Er / Yb / Y using pyridine and pyrazine-based naphthylsalophen ligands display Er(lll) centered emission showing two-photon up-conversion. The presence of N atom(s) in the diamine backbone affects the TT-TT interactions between the naphthylsalophen ligands in the Ln(lll) complexes, resulting in a close M-M (metal to metal) distance.Synthesis of Ligands
[0120] As disclosed herein, the following examples describe synthesis and characterization of ligands used to form Ln(lll) complexes associated with the [Ln2 (Lx)s] formula. In one or more embodiments, as disclosed above the Lxmay include the ligand represented by Formula (VI), Formula (VII), Formula (VIII), or combinations thereof. In one or more embodiments, as described below, the ligand of Formula (VI) may be referred to as H2L1, the ligand of Formula (VII) may be referred to as H2L2, and the ligand of Formula (VIII) may be referred to as H2L3. As shown in Figure 2, the Lxinclude two -OH groups before reacting to form the Ln(lll) complex. The H2L1, H2L2, and H2L3ligands are formed via Schiff base condensation reactions between diaminePATENTAttorney Docket No.: TXTU / 0012PCand aldehyde precursors and are subsequently used to synthesize Ln(lll) complexes, including Ln(l 11) complexes having the general formula Ln2(L)3.
[0121] H2L1, H2L2, and H2L3were isolated by means of a condensation reaction using 2,3-pyridinediamine, 2,6-pyridinediamine, or 2,3-pyrazinediamine with two equivalents of 2-hydroxy-1 -naphthaldehyde, TEA in MeOH to obtain tetradentate Schiff base ligands. The reaction resulted in the formation of solid precipitates with yields ranging between 45%-75% after 24 hours. The ligands H2L1, H2L2, and H2L3are shown in Figure 2as part of a synthesis schematic for forming the 3:2 ligand-to-lanthanide sandwich-type metal complexes (e g., [Ln? (Lx)s]).Example 4: H2L1
[0122] Example 4 represents forming the ligand H2L1. 2,3-Diaminopyridine (0.100 g, 0.916 mmol), TEA (256 ptL, 3.664 mmol), and 2-hydroxynaphthaldehyde (0.3154 g, 1.832 mmol) were added to 10 mL of MeOH in a 50 mL round bottom flask and allowed to stir at room temperature for 24 hours. During this time, the solution changed from yellow to brown resulting in a dirty yellow precipitate formation. The resulting solid was filtered and washed with hexanes to yield a pale-yellow powder (0.1732 g, 45.34 %). Example 4 was characterized with the following results: FT-IR (v, cm'1) 3392 (Broad O-H); 3023 (Aro C-H); 1618 (C=N), 1277 (C-O).Example 5: H2L2
[0123] Example 5 represents forming the ligand H2L2. 2,3-Diaminepyrazine (0.100 g, 0.9081 mmol), TEA (505 pL, 3.6324 mmol), and 2-hydroxynaphthaldehyde (0.3127 g, 1.8162 mmol) were added to 10 mL of MeOH in a 50 mL round bottom flask and allowed to stir at room temperature for 24 hours. During this time, the solution changed from yellow to brown and an orange yellow precipitate was formed. The resulting solid was filtered and washed with MeOH and hexanes to yield a light orange powder (0.163 g, 43.08 %). Example 5 was characterized with the following results: FT-IR (v, cm-1) 3351 (Broad O-H); 3054 (Aro C-H); 1616 (C=N); 1274 (C-O).Example 6: H2L3PATENTAttorney Docket No.: TXTU / 0012PC
[0124] Example 6 represents forming the ligand H2L3. 2,6-Diaminopyridine (0.100 g, 0.916 mmol), TEA (256 L, 3.664 mmol), and 2-hydroxynaphthaldehyde (0.3154 g, 1.832 mmol) were added to 10 mL of MeOH in a 50 mL round bottom flask and allowed to stir at room temperature for 24 hours. During this time, the solution changed from yellow to brown and a pale-yellow precipitate was formed. The resulting solid was filtered and washed with MeOH and hexanes to yield a dark yellow powder (0.2802 g, 73.35 %). Example 6 was characterized with the following results:1H NMR (400 MHz, CDCh) 510.02 (s, 2H), 8.17 (s, 2H), 7.82-7.76 (m, 4H), 7.66 (d, 1H, J - 7.4 Hz), 7.58-7.54 (m, 6H), 6.94 (s, 2H), 6.92 (s, 2H). FT-IR (v, cm'1) 3370 (Broad O-H); 3024 (Aro C-H); 1618 (ON); 1284 (C-O) TOF MS (ESI) m / z [M+H]1+C27H19N3O2 (Calc.) 417.1453, (Found) 417.1457 Elemental Analysis (Calc. %) for C23H18N3O2: C, 74.9; H, 4.9; N, 11.4; (Found %) C, 74.7; H, 4.5; N, 11.8.Synthesis ofLn(lll) Complexes with the [Ln2(Lx)3MeOH] general formula
[0125] The Ln(lll) complexes were synthesized using the solution of isolated ligands in equal amounts of MeOH and DCM with two-third equivalents of chloride salt of lanthanides and TEA to obtain 3:2 ligand-to-lanthanide sandwich complexes Ln2(L1)s(MeOH), Ln2(L2)3(MeOH), and Ln2(L3)s(MeOH), as shown in Figure 2. The sulfonated Ln(lll) complexes Ln2(L’1)3(MeOH), Ln2(L’2)3(MeOH), and Ln2(L’3)3(MeOH) were isolated through a one-pot synthesis reaction using pyridyl or pyrazine diamine, TEA, two equivalents of sodium 5-formyl-6-hydroxy naphthalene-2-sulfonate, with two-third equivalents of lanthanide chloride in MeOH. The sulfonated Ln(lll) complexes were obtained in 50-70 % yield. The mixed Ln(lll) metal complexes containing Er / Yb and Er / Yb / Y were synthesized in a very similar fashion to the mononuclear Ln(lll) naphthylsalophen pyridyl and pyrasal complexes. A solution of two third equivalents of chlorides of Er(lll), Yb(lll), Y(lll) in MeOH was added to the ligands. The mixed metal ratios were selected based on the similar cyano-naphthylsalophen Ln(lll) complexes.Example 7; Er2(L’)s and Gd2(Lr
[0126] Er2(L1)3 (Cs^saE^NsOg) was formed according to the above method. The unsulfonated Ln(lll) metal complexes (Er2(L1)3 and Gd2(L1)a) were crystallized by thePATENTAttorney Docket No.: TXTU / 0012PCslow evaporation of reaction mixtures from MeOH solutions. The crystallographic data obtained for the complex Er2(L1)3 is reported in Table 3.Table 30127] Figure 15A shows a projection of the front view of Er2(L')3. Figure 15B shows coordination spheres of Er1 and Er2. Figure 15C shows a projection of the side view of Er2(L1)3. Figure 15D shows a projection of the front view of Gd2(L1)3. Figure 15E shows coordination spheres of Gd1 and Gd2. Figure 15F shows a projection of the side view of Gd2(L1)3. Interstitial solvent molecules and hydrogen atoms, except those involved in hydrogen bonding, have been removed for clarity.
[0128] The metal complex Er2(L1)3(CwHesE^NsOg), is shown in Figures 15A and 15B crystallized in the triclinic system with the space group P~1, containing two interstitial methanol (MeOH) molecules per asymmetric unit. Figure 15B shows the coordination sphere around the erbium ions occupied by the naphthyl salophenPATENTAttorney Docket No.: TXTU / 0012PCligands stacked in a 3-layer sandwich-like structure. The top Er is 8-coordinate due to linkage with the ligands, while the bottom Er is 7-coordinate, binding with the ligand and one MeOH molecule. The distance between Er centers was found to be 3.8007(3) A. The Gd(lll) complex, Gd2(Li)3 (C84H6iCl2Gd2NgO8), is shown in Figures 15D and 15E and crystallized in the triclinic P”1 space group, containing interstitial MeOH and chloroform (CHCE) molecules. Figure 15E shows the coordination sphere around the Gd ions. The Gd centers are coordinated to the tetradentate ligands, where the top Gd is bound to the ligands and the ligand around the bottom Gd show weak hydrogen bonding with the surrounding MeOH molecules along with the ligand interaction. The distance between the two Gd metal centers, 3.8992(4) A, lies within the Forster energy transfer range. The crystal’s TT-TT interactions from the adjacent aromatic rings help stabilize the complex and facilitate the stacking of ligands into the three layered sandwich structure. The structure of the naphthyl salophen directly influences the coordination environment. The ligand’s planar structure and presence of multiple coordination sites (O and N atoms) help stabilize the complex.Exampie 8: [Ln2(L1)3(MeOH)]
[0129] The ligand L1(0.100 g, 0.2395 mmol) was dissolved in a mixture of 30 mL DCM and 30 mL MeOH in a 250 mL round bottom flask. The Ln(lll) chloride (Ln(lll) = Er(lll), Gd(lll), Yb(lll)) (0.1595 mmol) was dissolved in MeOH and added to the solution, followed by the addition of triethylamine (TEA) (133 pL, 0.958 mmol). The solution was refluxed for about 24 hours. The solution volume was reduced by half using a rotary evaporator, and the subsequent solution was allowed to evaporate slowly. X-ray quality crystals were filtered and washed with hexanes after about 18 hours.
[0130] In one or more embodiments, the synthesis yields: Er2(L1)s- 0.0908 g, 70.50 %, Gd2(L1)3- 0.0997 g, 78.44 %, and Yb2(L1)3- 0.1034 g, 79.74 %. Example 8 was characterized with the following results: Er2(L1)3- FT-IR (v, cm-1) Er2(L1)s3014 (Aro C-H); 1600 (C=N); 1288 (0-0). Er2(L1)3- (TOF MS (ESI) m / z [M + H]1+C81 HssNgOeE^ (Calc.) 1582.2757 g, (Found) 1582.2754. Er2(L!)3- Elemental analysis for C8lH5lN8O6Er2 H2O-4CH2Cl2 (calcd %) C, 53.1; H, 3.2; N, 5.8 (found %): C, 53.8; H, 3.2; N, 5.5. Gd2(L1)3-(TOF MS (ESI) m / z [M + H]1+C81 H55NgO6Gd2 (Calc.)PATENTAttorney Docket No.: TXTU / 0012PC1565.9462, (Found) 1565.9460. Gd2(L1)3- Elemental analysis for C84H5lNgO6Gd2-6H2O (Calc. %) C, 59.1; H, 3.7; N, 7.4 (Found %) C, 59.1; H, 3.3; N, 7.5. Yb2(Li)3- (TOF MS (ESI) m / z [M + H]1+C8lH48N O6Yb2 (Calc.) 1589.9748, (Found) 1589.9799.Example 9: [Ln2(L2)3MeOH]
[0131] The ligand L2(0.100 g, 0.239 mmol) was dissolved in a mixture of 30 mL DCM and 30 mL MeOH in a 250 mL round bottom flask. Ln(lll) chloride (Ln(lll) = Er(lll), Gd(lll), Yb(lll)) (0.1592 mmol) was dissolved in MeOH and added to the solution, followed by the addition of triethylamine (TEA) (133 pL, 0.958 mmol). The solution was refluxed for 4 hours. During this time, the color changed from light orange to dark orange. The solution volume was reduced by half using a rotary evaporator, and the subsequent solution was allowed to evaporate slowly. The metal complex was filtered and washed with MeOH and hexanes to obtain precipitates.
[0132] In one or more embodiments, the synthesis yields: Er(L2)a: (0.1007 g, 78.33 %) and Gd(L2)3: (0.1015 g, 79.90 %), and Yb(L2)3: (0.1048 g, 80.82 %). Example 9 was characterized with the following results: Er(l 11) - (TOF MS (ESI) m / z (M + H)+C78H48N12O6Er2(Calc.) 1582.2739 g, (Found) 1582.2739 (This accounts for one H atom) Elemental analysis for C78H48N12O6Er2-9H2O (Calc. %) C, 53.7; H, 3.8; N, 9.6 (Calc. %) C, 53.7; H, 3.2; N, 9.3. Gd(lll)- (TOF MS (ESI) m / z (M + H)+C78H47N12O6Gd2(Calc.) 1563.9387, (Found) 1563.9387. Elemental analysis for C75H45Ni2O6Gd2.i0H2O (Calc. %) C, 52.8; H, 3.8; N, 9.8 (Found %) C, 52.9; H, 3.2; N, 9.3. Yb(lll)- (TOF MS (ESI) m / z [M + H]1+C81 H47NgO6Yb2 H2O (Calc.) 1612.7166, (Found) 1612.7164.Example 10: [Ln2(L3)3MeOH]
[0133] The ligand L3(0.100 g, 0.2395 mmol) was dissolved in a mixture of 30mL DCM and 30 mL MeOH in a 250 mL round bottom flask. Ln(lll) chloride (Ln(lll) ~ Er(lll), Gd(lll), Yb(lll)) (0.1595 mmol) was dissolved in MeOH and added to the solution, followed by the addition of triethylamine (TEA) (133 uL, 0.958 mmol). The solution was refluxed for 24 hours. During this time, the color changed from light orange toPATENTAttorney Docket No.: TXTU / 0012PCdark orange. The solution volume was reduced by half using a rotary evaporator, and the subsequent solution was allowed to evaporate slowly. The metal complex was filtered and washed with MeOH and hexanes to obtain precipitates.
[0134] In one or more embodiments, the synthesis yields Er(L3)3: (0.0848 g, 65.94 %) and Gd(L3)3: (0.0998 g, 78.53 %), and Yb(L3)3: (0.0848 g, 65.43 %). Example 10 was characterized with the following results: Er(lll) - (TOF MS (ESI) m / z (M + 1H)+C81H51N9O6Er2(Calc.) 1579.2884 g, (Found) 1579.2896 (This accounts for one H atom) Elemental analysis for C8lH5lN7O6Er2-12CH2CI2(Calc. %) C 43.6; H 2.6; N, 3.8 (Found %): C, 43.3; H, 2.7; N, 3.8 GdIH- (TOF MS (ESI) m / z (M + H)+C81H54N9O6Gd2(Calc.) 1564.5869, (Found) 1564.5868. Elemental analysis for C8lH42N9O6Gd2.i4H2O (Calc. %) C, 53.9; H, 3.9; N, 6.9 (Found %): C, 53.9; H, 3.3; N, 6.4. Yb(lll)- (TOF MS (ESI) m / z [M + H]1+C81 H56NgO6Yb2 (Calc.) 1597.3265, (Found) 1597.3269.Sulfonated Pyridyl and Pyrasal Ln(lll) Complex [Ln? (Lx)3(MeOH)J ExamplesExample 11: Synthesis of sodium 5-formyl-6-hydroxy naphthalene-2-sulfonate
[0135] 2-Hydroxy-1 -naphthaldehyde (1.291 g, 7.5 mmol) was added into 12.5mL concentrated sulfuric acid in the ice-water bath dropwise. The reaction mixture was stirred for 18 hours at 40 °C. The reaction mixture was subsequently stirred at 70°C for an hour and filtered. NaCI (8 g) was added into the hot filter liquor. After cooling to room temperature, a pink powder was precipitated and filtered. The solid was washed by saturated sodium chloride solution, and ethanol. The resulting solid was recrystallized using ethanol to yield a light pink solid in 81 % yield. FT-IR (v, cm'1) 3397 (O-H); 3046 (C-H); 1038, 967 (SO3). The following examples refer to the disclosed modified (substituted) phenylenediamine-derived Schiff base ligand with a 2,3-pyridine core or to the substituted (functionalized) phenylenediamine-derived Schiff base ligand with a 2,3-pyrazine core.Example 12: [Ln2(L’1)3(MeOH)J
[0136] In the equation [Ln2(L.’')3(MeOH)], L’1refers to a sulfonated H2L1. 2,3-Diaminopyridine (0.100 g, 0.916 mmol), TEA (509 uL, 3.664 mmol), and sodium 5-PATENTAttorney Docket No.: TXTU / 0012PCformyl-6-hydroxy naphthalene-2-sulfonate (0.502 g, 1.832 mmol) were added to 30 mL of MeOH in a 100 ml round bottom flask until dissolved. Two third equivalents of Ln(lll) chloride (Ln(lll) = Er(lll), Yb(lll) Lu(lll)) (0.610 mmol) dissolved in MeOH (10 mL) were added to the reaction mixture and kept under stirring for 24 hours at 40°C to obtain a solid. The resulting solid was filtered and washed with methanol and hexanes to yield the metal complex. In one or more embodiments, the synthesis yields: Er2(L’1)3- 0.2690 g, 39.60 %, Yb2(L’1)3- 0.4240 g, 62.14 %, and Lu2(L’1)3- 0.1480 g, 21.62 %. Example 12 was characterized with the following results: Er2(L’i)3- (TOF MS (ESI) m / z [M+H]uCs^sNgC^SsE^ (Calc.) 2054.1349, (Found) 2054.1348. Er2(L'1)3- Elemental analysis C8iH45N9O24S6Na6Er2-6ErCl3'3NEt3-11NaCI (calcd %) C, 24.79; H, 1.85; N, 3.61 (found %) C, 24.87; H, 1.89; N, 3.52. Yb2(L’1)3- (TOF MS (ESI) m / z [M+2H]2+C8iH53NgO24S6Yb2(Calc.) 1037.4686, (Found) 1037.4686. LU2(L’1)3- (TOF MS (ESI) m / z [M+H]1+C8iH54NgO24S6Lu2(Calc.) 2078.1286, (Found) 2078.1282 Lu2(LT)3-1H NMR (700 MHz, DMSO-d6) 6 10.77 (s, 3H), 10.12 (s, 3H), 9.37 (s, 6H), 8.88 (s, 3H), 7.43 (m, 6H), 7.26 (s, 6H), 6.98 (d, 6H, J = 8.4 Hz), 5.98 (s, 3H), 5.88 (s, 9H). Example 12: [(Yb0.83Ero.i7)2(L,1)3(MeOH)]
[0137] 2,3-diamino pyridine (0.100 g, 0.916 mmol), TEA (509 μL, 3.664 mmol), and sodium 5-formyl-6-hydroxy naphthalene-2-sulfonate (0.502 g, 1.832 mmol) were added to 30 mL of MeOH in a 100 mL round bottom flask until dissolved. Ln(lll) chloride solutions, in MeOH (10 mL), containing a mixture of Yb(lll) and Er(lll) (Yb: 0.2127 g, 0.549 mmol; Er: 0.0233 g, 0.061 mmol) were added to the solution of the deprotonated ligand in 2:3 (Ln: L) molar ratio, and kept under stirring for 24 hours at 40°C. The resulting solid was filtered and washed with methanol and hexanes to yield the metal complex (0.3080 g, 48.81%). ICP-MS (83.01 ±0.21) % Yb, (16.99+0.17) % Er.Example 13: [(Yo.89Ybo.o8Er0.o2)2(L,1)3(MeOH)]
[0138] 2,3-Diaminopyridine (0.100 g, 0.916 mmol), TEA (509 μL, 3.664 mmol), and sodium 5-formyl-6-hydroxy naphthalene-2-sulfonate (0.502 g, 1.832 mmol) were added to 30 mL of MeOH in a 100 mL round bottom flask until dissolved. Ln(lll) chloride solutions, in MeOH (10 mL), containing a mixture of Y(lll), Yb(lll) and Er(lll)PATENTAttorney Docket No.: TXTU / 0012PC(Y: 0.1425 g, 0.4697 mmol; Yb: 0.0473 g, 0.122 mmol; Er: 0.0069 g, 0.0183 mmol) were added to the solution of the deprotonated ligand in 2:3 (Ln: L) molar ratio, and kept under stirring for 4 hours at 40°C. The resulting solid was filtered and washed with methanol and hexanes to yield the metal complex (0.4410 g, 69.80 %). ICP-MS (89.34±0.46) % Y, (8.38+0.07) % Yb, (2.34±0.07) % Er.Example 14: [Ln2(L’2)3(MeOH)]
[0139] In the equation [Ln2(L’2)3(MeOH)]. L’2refers to a sulfonated H2L2. 2,3-diamino pyrazine (0.100 g, 0.9081 mmol), TEA (505 μL, 3.6324 mmol), and sodium 5-formyl-6-hydroxy naphthalene-2-sulfonate (0.498 g, 1.8162 mmol) were added to 30 mL of MeOH in a 100 mL round bottom flask until dissolved. Two third equivalents of Ln(lll) chloride (Ln(l 11) = Er(lll), Yb(lli) Lu(lll)) (0.6047 mmol) dissolved in MeOH (10 mL) were added to the reaction mixture and kept under stirring for 24h at 40°C to obtain a solid. The resulting solid was filtered and washed with methanol and hexanes to yield the metal complex.
[0140] In one or more embodiments, the synthesis yields: Er2(L’2)3- 0.2630 g, 39.09 %, Yb2(L'2)3- 0.4080 g, 60.20 %, and Lu2(L’2)3- 0.3210 g, 47.11 %. Example 14 was characterized with the following results: Er2(L’2)3- FT-IR (v, cm-1) 3019 (C-H); 1630 (C=N); 1099, 995 (SO3-); 612 (Er-O). Er2(L’2)3- (TOF MS (ESI) m / z C78H4oN12024S6Er2 [M+H]1+(Calc.) 2055.1878, (Found) 2055.1865. Er2(L’2)3-Elemental analysis C7sH4oNi2024SeEr26ErCI3-2NEt312NaCI (calcd %) C, 23.51; H, 1.54; N, 4.23 (found %) C, 23.49; H, 1.53; N, 4.26. Yb2(L’2)3- (TOF MS (ESI) m / z [M+2H]2+C75H36N12O-|8S4Yb2(Calc.) 934.8806, (Found) 934.8806. Lu2(L’2)3-(TOF MS (ESI) m / z [M+2H]2+C78H42N12O25S6Lu2CH3OH (Calc.) 2119.31, (Found) 2119.3145. Lu2(L’2)3-1H NMR (700 MHz, D2O) 58.44 (s, 6H), 7.81 (s, 3H), 3.34 (s, 3H), 3.21-3.18 (m, 6H), 2.92-2.90 (m, 6H), 1.78-1.73 (m, 6H), 1.28 (s, 3H), 0.64-0.61 (m, 6H), 0.15 (d, 3H, J - 1.3 Hz).Example 15: [(Yb0.9oEr0.10)2(L,2)3(MeOH)]
[0141] 2,3-Diaminopyrazine (0.100 g, 0.908 mmol), TEA (505 μL, 3.632 mmol), and sodium 5-formyl-6-hydroxy naphthalene-2-sulfonate (0.498 g, 1.816 mmol) werePATENTAttorney Docket No.: TXTU / 0012PCadded to 30 mL of MeOH in a 100 mL round bottom flask until dissolved. Ln(lll) chloride solutions, in MeOH (10 mL), containing a mixture of Yb(lll) and Er(lll) (Yb: 0.2109 g, 0.5445 mmol; Er: 0.0230 g, 0.0605 mmol) were added to the solution of the deprotonated ligand in 2:3 (Ln: L) molar ratio, and kept under stirring for 24h at 40°C. The resulting solid was filtered and washed with methanol and hexanes to yield the metal complex (0.3080 g, 49.14 %). ICP-MS (89.86±0.47) % Yb, (10.14±0.29) % Er.Example 16: [(Y0.9iYbo.o7Ero.o2)2(L,2)3(MeOH)]
[0142] 2,3-Diaminopyrazine (0.100 g, 0.908 mmol), TEA (505 μL, 3.632 mmol), and sodium 5-formyl-6-hydroxy naphthalene-2-sulfonate (0.498 g, 1.816 mmol) were added to 30 mL of MeOH in a 100 mL round bottom flask until dissolved. Ln(lll) chloride solutions, in MeOH (10 mL), containing a mixture of Y(lll), Yb(lll) and Er(ill) (Y: 0.1414 g, 0.466 mmol; Yb: 0.0469 g, 0.121 mmol; Er: 0.0069 g, 0.0182 mmol) were added to the solution of the deprotonated ligand in 2:3 (Ln: L) molar ratio, and kept under stirring for 24h at 40°C. The resulting solid was filtered and washed with methanol and hexanes to yield the metal complex (0.4440 g, 70.82 %). ICP-MS (91.05±0.63) % Y, (6.99±0.16) % Yb, (2.02±0.16) % Er.Example 17: [Ln2(L’3)3(MeOH)]
[0143] In the equation [Ln? (L’3)3(MeOH)], L’s refers to a sulfonated H2L3. 2,6-Diaminopyridine (0.100 g, 0.916 mmol), TEA (509 μL, 3.664 mmol), and sodium 5- formyl-6-hydroxy naphthalene-2-sulfonate (0.502 g, 1.832 mmol) were added to 30 mL of MeOH in a 100 mL round bottom flask until dissolved. Two third equivalents of Ln(lll) chloride (Ln(lll) = Er(lll), Yb(lll), Lu(lll)) (0.610 mmol) dissolved in MeOH (10 mL) were added to the reaction mixture and kept under stirring for 24h at 40°C to obtain a solid. The resulting solid was filtered and washed with methanol and hexanes to yield the metal complex.
[0144] In one or more embodiments, the synthesis yields: Er2(L'3)3- 0.3380 g, 49.82 %, Yb2(L’3)3- 0.4320 g, 63.31 %, and Lu2(L’3)3- 0.3620 g, 53.04 %. Example 17 was characterized with the following results: Er2(L’3)3- FT-IR (v, cm-1) 3019 (C-H); 1631 (C=N); 1099, 996 (SO3-); 611 (Er-O). Er?(L’3)3- (TOP MS (ESI) m / z [M+H]1+^82^51 NgO25S@Er2 (This accounts for one CH3OH molecule) (Calc.) 2089.3129,PATENTAttorney Docket No.: TXTU / 0012PC(Found) 2089.3118. Er2(L’3)3- Elemental analysis C82H5iN9O25S6Er2-6ErCl3-2NEt3 HNaCI (calcd %) C, 24.70; H, 1.86; N, 3.37 (found %) C, 24.67; H, 1.78; N, 3.37. Yb2(L’3)3- (TOF MS (ESI) m / z [M+2H]2+C8iH39N9O24S6Yb2 H2O CH3OH (Calc.) 1058.4635, (Found) 1058.4628. Lu2(L’3)3- (TOF MS (ESI) m / z [M+H]1+CQI H45N9O24S6L. U2 (Calc.) 2062.8942, (Found) 2062.8943. Lu2(L’3)3-1H NMR (700 MHz, DMSO-d6) 5 15.24 (s, 1H), 10.29 (s, 6H),7.96 (s, 3H), 7.92 (t, 3H, J= 8.5 Hz), 7.75 (dd, 2H, J = 8.6 Hz, 1.8 Hz), 7.70-7.63 (m, 6H), 7.50 (t, 2H, J= 7.8 Hz), 7.36 (d, 2H, J= 7.8 Hz), 7.03 (t, 1H, J = 7.7 Hz), 6.90 (d, 2H, J = 9.2 Hz), 6.82 (d, 3H, J = 7.4 Hz), 6.64 (d, 3H, J = 7.4 Hz), 6.48 (d, 2H, J = 8.2 Hz), 6.39 (d, 2H, J = 8.1 Hz), 6.34 (s, 3H), 5.64 (d, 3H, J = 8.2 Hz), 5.35 (s, 3H).Example 18: [(Yb0.82ErQ.18)2(E3)3(MeOH)]
[0145] 2,6-Diaminopyridine (0.100 g, 0.916 mmol), TEA (509 μL, 3.664 mmol), and sodium 5-formyl-6-hydroxy naphthalene-2-sulfonate (0.502 g, 1.832 mmol) were added to 30 L of MeOH in a 100 mL round bottom flask until dissolved. Ln(lll) chloride solutions, in MeOH (10 mL), containing a mixture of Yb(lll) and Er(lll) (Yb: 0.2127 g, 0.549 mmol; Er: 0.0233 g, 0.061 mmol) were added to the solution of the deprotonated ligand in 2:3 (Ln: L) molar ratio, and kept under stirring for 24h at 40°C. The resulting solid was filtered and washed with methanol and hexanes to yield the metal complex (0.3280 g, 52.08 %). ICP-MS (82.47±0.36) % Yb, (17.53±0.05) % Er.Example 19: [(Yo.9oYbo.o8Ero.o2)2(L’3)3(MeOH)]
[0146] 2,6-Diaminopyridine (0.100 g, 0.916 mmol), TEA (509 μL, 3.664 mmol), and sodium 5-formyl-6-hydroxy naphthalene-2-sulfonate (0.502 g, 1.832 mmol) were added to 30 mL of MeOH in a 100 mL round bottom flask until dissolved. Ln(lll) chloride solutions, in MeOH (10 mL), containing a mixture of Y(lll), Yb(lll) and Er(lll) (Y: 0.1425 g, 0.4697 mmol; Yb: 0.0473 g, 0.122 mmol; Er: 0.0069 g, 0.0183 mmol) were added to the solution of the deprotonated ligand in 2:3 (Ln: L) molar ratio, and kept under stirring for 24h at 40°C. The resulting solid was filtered and washed with methanol and hexanes to yield the metal complex (0.3320 g, 52.63 %). ICP-MS (90.23±0.25) % Y, (7.60±0.09) % Yb, (2.17±0.08) % Er.PATENTAttorney Docket No.: TXTU / 0012PCPhotophysical Characterization of Pyridyl and Pyrasal Naphthylsalophen Ln(lll) Complexes [Ln2(Lx)3(MeOH)J Examples
[0147] The energies of singlet and triplet states were obtained from the fluorescence and phosphorescence of the analogous Gd(lll) complexes and are listed in Table 4. The triplet energies of the ligands are suitable for sensitization of Yb(lll) and Er(lll), as the excited states2Fs / 2 and4I13 / 2for Yb and Er are about 10,000 cm-1and about 7,000 cm-1respectively. The Ln(lll) complexes demonstrated the metalcentered emission of Yb(lll) or Er(lll) and the one-photon excitation and emission spectra of the Er(lll) and Yb(lll) complexes were obtained in DMSO. The excitation spectra of the Ln(lll) complexes show broad bands, which are indicative of sensitization of Ln(lll) through the ligand and are slightly red shifted compared to the absorbance. The emission spectra show the characteristic Er(lll) and Yb(lll)-centered transitions,4li3 / 2—4lis / 2 and2Fs / 2— >2F7 / 2, respectively. The lifetimes of the Ln(lll) complexes are listed in Table 1 and are consistent with other Yb(lll) complexes. The excited state decay curves of the2Fs / 22F7 / 2transition were fitted with bi-exponential, which was consistent with two Yb coordination environments. The quantum yields of emission for the Yb(lll) complexes are listed in Table 4 and are comparable to reported values for other Yb-based complexes. In Table 4 singlet (’S) and triplet (3T) state energies of the ligands, excited state lifetime (T), coordinated solvent molecules (q), and quantum yield of sensitized emission (<pLn) are shown.Table 4PATENTAttorney Docket No.: TXTU / 0012PCaDetermined from the fluorescence and phosphorescence spectra at 77 K after deconvolution and indicated as the zero-phonon band
[0148] The Ln(l I l)-Ln(ll I) metal distance was 3.801 A, which is favorable for Forster energy transfer. The UC emission was observed in the solid state for Ln(lll) complexes without the sulfonate groups. UC emission for [Er2(L1)3(MeOH)] and [Er2(L2)3(MeOH)] exhibited intensity that was too low for power dependence studies. However, [Er2(L3)3(MeOH)] showed higher emission intensity, and a quadratic dependence on laser power could be observed. Conversely, the aforementioned Ln(lll) complexes were not water-soluble. To observe UC emission in aqueous solutions, the Ln(lll) complexes were isolated with ligands functionalized with sulfonate groups (e.g., examples 12-19). The UC emission was observed in solid state with dierbium, as shown in Figures 16A and 16B. Figure 16A shows two-photon UC emission spectra of [Er2(L’3)3(MeOH)] in the solid state using variable laser power. Figure 16B shows a plot of the log of the emission intensity of the transitions2Hn / 24lis / 2 (yellow squares),4S3 / 24115 / 2 (blue circles), and4Fe / 2 —>4lis / 2 (black triangles) as a function of the log of the laser power P. I = 980 nm, P = 0.593-2.500 W, integration time: 20s.PATENTAttorney Docket No.: TXTU / 0012PC
[0149] [Er2(L’3)3(MeOH)] was excited at 980 nm into the Er(lll)4I 15 / 2 — ►4ll1 / 2 transition, and the resulting spectra showed Er(lll)-centered emission with the transitions in the blue2Hi 1 / 24115 / 2, green4S3 / 24lis / 2, and red4Fg / 24115 / 2 shown in Figure 16A. The logarithmic quadratic dependence of the emission intensity (I) on laser power (P) shown in Figure 16B confirms the 2-photon nature of the process. The UC emission was observed with power densities as low as 1.48 W / cm2, lower than seen for other Ln(lll) complexes at 2.18 W / cm2.
[0150] Typically, mixed Ln(lll) metal complexes exhibit a higher UC emission intensity due to the decrease in cross-relaxation between adjacent Er(lll) and the higher absorption coefficient of Yb(lll). The energy gap between the excited state (2FS / 2) of Yb(l II) and the ground state (2Fz / 2) is equal to that of a 980 nm photon. Additionally, the2Fz / 2->2Fs / 2transition matches the energy levels of Er(lll) (4lu / 2), which helps improve the probability of UC emission. Here, a 37-fold increase in emission intensity was demonstrated with the mixed metal complex, as shown in Figures 17A. Figure 17A shows the two-photon UC emission spectra of [Ero9Ybo.i(L’3)3(MeOH)] in the solid state using variable laser power. Figure 17B shows the plot of the log of the emission intensity of the transitions2Hn / 24li5 / 2(squares),4S3 / 2-4lis / 2(circles), and4Fg / 24lis / 2(triangles) as a function of the log of the laser power P. ex = 980 nm, P = 0.593-2.500 W, integration time: 20s. The other mixed Ln (111) metal complexes disclosed herein exhibited a similar increase in UC emission. As the mixed Ln(lll) metal complexes had higher intensity in the solid state, the mixed Ln(lll) metal complexes were investigated in aqueous solutions. In one or more embodiments, UC was observed in water for the [Eroi7Ybo.83(L’')3(MeOH)]complex at a low intensity. Figure 18 shows the two-photon UC emission spectrum of [Ero 1 zYbo B3(L’1)3(MeOH)] in water. Xex = 980 nm, P = 2.500 W, integration time: 20s.Multi-metallic Naphthylsalophen Sulfonate Ln(lll) Complexes [L fL fHiO)] Examples
[0151] The multi-metallic naphthylsalophen sulfonate Ln(lll) complexes, also referred to as the sulfonated naphthaldehyde Ln(lll) complexes, were synthesized according to methods similar to those described above. The Ln(lll) complexes werePATENTAttorney Docket No.: TXTU / 0012PCobtained through condensation of substituted diaminobenzenes, sodium 5-formyl-6-hydroxy naphthalene- 1 -sulfonate, triethylamine (TEA) and the desired Ln(lll) chloride hydrate or mixture of Ln(l II) salts, where the ratios were chosen based on previous successful UC systems. The below examples show the 9 multi-metallic naphthylsalophen sulfonate Ln(lll) complexes. The Lxof the representative Equation (I) are numbered 1-9 to denote the different ligands in the complex. The formation of the Ln(lll) complexes was confirmed by1H NMR, PXRD, ESI-TOF mass spectrometry, and elemental analysis.Example 20: Synthesis of sodium 5-formyl-6-hydroxy naphthalene-2-sulfonate
[0152] 2-Hydroxy-1 -naphthaldehyde (1.291 g, 7.5 mmol) was added into 12.5mL concentrated sulfuric acid in the ice-water bath dropwise. The reaction mixture was stirred for 18 hours at 40 °C. The reaction mixture was subsequently stirred at 70°C for an hour and filtered. NaCI (8 g) was added into the hot filter liquor. After cooling to room temperature, a pink powder was precipitated and filtered. The solid was washed by saturated sodium chloride solution, and ethanol. The resulting solid was recrystallized using ethanol to yield a light pink solid in 81% yield. Example 20 was characterized with the following results: FT-IR (v, cm'1) 3397 (O-H); 3046 (C-H); 1392, 1188 (SOs); 1236 (C-O).Example 21: Synthesis of [Ln^L^HzO)]
[0153] 1,2-Diaminobenzene (0.100 g, 0.925 mmol), TEA (515 μL, 3.70 mmol), and sodium 5-formyl-6-hydroxy naphthalene-2-sulfonate (0.507 g, 1.85 mmol) were added to 30 mL of MeOH in a 100 mL round bottom flask until dissolved. Two third equivalents of Ln(lll) chloride hydrate (Ln(lll) = Er(lll), Gd(lll), Yb(lll), Lu(lll)) (0.610 mmol) dissolved in MeOH (10 mL) were added to the reaction mixture and kept under stirring for 24h at 40°C to produce precipitates. The resulting solids were filtered and washed with methanol and hexanes.
[0154] In one or embodiments, the synthesized compounds yielded: Er2(L1)3: 0.331 g, 49 %, Gd2(L1)3: 0.239 g, 35 %, Yb2(L1)3: 0.362 g, 53 %, Lu2(L’)3: 0.295 g, 43 %.PATENTAttorney Docket No.: TXTU / 0012PC
[0155] Example 21 was characterized with the following results: Er2(L' )s- FT-IR ( v, cm~1) 3019 (C-H); 1602 (C=N); 1369,1183 (SO3; 1290 (C-O). Er2(L1)3- (TOF MS (ESI) m / z [M+2H]2+CMb NeC^SeE^ (Calc.) 1023.4047, (Found) 1023.4003. Elemental analysis for CsoHsoNeC^SsE^. T^O (Calc. %) C, 47.66; H, 2.84; N, 3.40 (Found %) C, 47.86; H,2.96; N, 3.28. Gd2(L1)3- (TOF MS (ESI) m / z [M+2H]2+C84H4iN6O2 S6Gd2 (Calc.) 1012.9605, (Found) 1012.9623. Yb2(L1)3- (TOF MS (ESI) m / z [M+2H]2+O84H52N6O2 S6Yb2(Calc.)1034.7143, (Found) 1034.7141. LU2(L1)3-1H NMR (700MHz, D2O) 68.18 (s, 6H), 7.80 (s, 6H), 7.47 (s, 6H), 7.40 (d, 6H, J = 7.1 Hz), 2.92 (s, 6H), 1.80-1.76 (m, 12H), 0.66 (dd, 3H, J - 1.3 Hz), 0.63 (dd, 3H, J = 1.3 Hz). Lu2(L1)3- (TOF MS (ESI) m / z [M+2H]2+C8 H50N6O24S6L. U2 (Calc.) 1034.9122, (Found) 1034.9080. PXRD: (Er2(L1)s) Percent crystallinity: 42.89% Unit cell index: P2 / m: 15.0784 / 9.3591 / 8.589490 / 90.56 / 90.Example 22: Synthesis of [(Ero.isYbo.82)2(L1)3(H20)]
[0156] Aliquots of 1,2-diaminobenzene (0.100 g, 0.925 mmol), TEA (515 μL, 3.70 mmol), and sodium 5-formyl-6-hydroxy naphthalene-2-sulfonate (0.507 g, 1.85 mmol) were added to 30 mL of MeOH in a 100 mL round bottom flask until dissolved. During this time, the solution changed from yellow to orange. Ln(lll) chloride solutions, in MeOH (10 mL), containing a mixture of Yb(lll) and Er(lll) (Yb: 0.554 mmol, 0.215 g; Er: 0.061 mmol, 0.0235 g) were added to the solution of the deprotonated ligand in 2:3 (Ln: L1) molar ratio, and kept under stirring for 24h at 40°C to produce a yellowish- brown precipitate. The resulting solid was filtered and washed with hexanes to yield a greenish brown powder (0.190 g, 53 %). Example 22 was characterized with the following results: FT-IR (v, cm’1) 3004 (C-H); 1600 (C=N); 1354, 1101 (SO3). ICP-MS- (82.23+0.38) % Yb, (17.77+0 11) % Er.Example 23: Synthesis of [Ln2(L2)3(H2O)J
[0157] 3,4-Diaminobenzonitrile (0.100 g, 0.751 mmol), TEA (418 μL, 3.004 mmol), and sodium 5-formyl-6-hydroxy naphthalene-2-sulfonate (0.412 g, 1.502 mmol) were added to 30 mL of MeOH in a 100 mL round bottom flask until dissolved to form a yellow solution. The Ln(lll) chloride (Ln(lll) = Er(III), Gd(lll), Yb(lll), Lu(lll)) (0.500 mmol) were dissolved in MeOH (10 mL), added to the solution of the deprotonatedPATENTAttorney Docket No.: TXTU / 0012PCligand in 2:3 (Ln: L2) molar ratio, and kept under stirring for 24h at 40°C to produce a greenish yellow solid on washing with hexanes.
[0158] In one or more embodiments, the synthesis yields: Er2(L2)3: 0.190 g, 33 %, Gd2(L2)3: 0.241 g, 43 %, Yb2(L2)3: 0.247 g, 43 %, and Lu2(L2)3: 0.252 g, 44 %.
[0159] Example 24 was characterized with the following results: Er2(L2)3-FT-IR (v, cm1) 3050 (C-H); 2220, (C=N); 1611 (C=N); 1369, 1097: (SO3j. Er2(L2)3- (TOF MS (ESI) m / z [M+2H]2+Cs7H49N9Na6O2S6Er2(Calc.) 1065.5500, (Found) 1065.5500. Er2(L2)3- Elemental analysis for C87H49N9Na6O24S6Na6Er2-22ErCl3-6NEt3-17NaCI-12H2O (Calc. %) C, 14.29: H, 1.60; N, 2.05 (Found %) 0,14.43; H, 1.60; N, 2.05. Gd2(L2)3-TOF MS (ESI) m / z [M+2H]2+C87H46N9O24S6Gd2(Calc.) 1054.0429, (Found) 1054.0435. Yb2(L2)3- (TOF MS (ESI) m / z [M+2H]2+C8H4iN9O2 S6Yb2.3H2O (Calc.) 1094.0177, (Found) 1094.0171. Lu2(L2)3-1H NMR (700MHZ, D2O) <54.79 (d, 6H, J = 12.1 Hz), 4.75-4.74 (m, 6H), 3.21-3.18 (m, 6H), 2.92-2.90 (m, 6H), 1.77-1.76 (m, 6H), 1.27 (t, 6H, J = 7.5 Hz), 0.63 (d, 3H, J = 7.3 Hz), 0.62 (d, 6H, J = 7.3 Hz). Lu2(L2)3- (TOF MS (ESI) m / z [M+2H]2+C87H43N9O24S6Lu2. H2O (Calc.) 1079.8367, (Found) 1079.8308. Er2(L2)3: PXRD Fddd, a= 12.31644A, b= 9.83331A, c=5.86636A; a= p= y = 90°; % crystall inity= 100%.Example 25: Synthesis of [Ln2(L3)3(H2O)] (PDTM-12, PDGd-12, PDYb-12, PDLu-12)
[0160] Aliquots of 4,5-diaminophthalonitrile (0.100 g, 0.632 mmol), TEA (352 μL, 2.528 mmol), and sodium 5-formyl-6-hydroxy naphthalene-2-sulfonate (0.346 g, 1.264 mmol) were added to 30 mL of MeOH in a 100 mL round bottom flask until dissolved to form a light pink solution. The Ln(lll) chloride (Ln(lll) = Er(lll), Gd(lll), Yb(lll), Lu(lll)) (0.420 mmol) were dissolved in MeOH (10 mL), added to the solution of the deprotonated ligand in 2:3 (Ln: L3) molar ratio, and kept under stirring for 24h at 40°C. The resulting precipitates were filtered and washed with hexanes.
[0161] In one or more embodiments, the synthesis yields: Er2(L3)3: 0.190 g, 38 %, Gd2(L3)3: 0.256 g, 52 %, Yb2(L3)3: 0.315 g, 63 %, Lu2(L3)3: 0.195 g, 40 %, Example 25 was characterized with the following results: Er2(L3)3FT-IR (v, cm-1) 3009 (C-H); 2232 (C=N); 1610 (C=N); 1363, 1104 (SO3“). Er2(L3)3- (TOF MS (ESI) m / z [M+2H]2+PATENTAttorney Docket No.: TXTU / 0012PCC9oH35Ni2024S6Er2-2H20 (Calc.) 1115.4025, (Found) 1115.4081. Er2(L3)3-Elemental analysis for C9oH42Ni5024S6Na6Er2-4ErCI3-11NaCI-30H2O CH3OH (Calc. %) C, 23.01; H, 2.30; N, 4.39 (Found %) C, 23.29; H, 2.28; N, 4.47. Gd2(L3)3- (TOF MS (ESI) m / z [M+2H]2+C9oH45Ni2023S6Gd2 (Calc.) 1092.8659, (Found) 1092.8658. Yb2(L3)3-(TOF MS (ESI) m / z [M+2H]2+CsoHseN^C^SeYb^^l-W (Calc.) 1122.0048, (Found) 1122.0092. LU2(L3)3-1H-NMR (700MHZ, D2O) <53.23 (d, 6H, J - 7.3 Hz), 3.21 (d, 6H, J = 7.3 Hz), 2.94-2.92 (m, 6H), 1.80-1.78 (m, 3H), 1.77-1.75 (m, 3H), 0.66 (s, 6H), 0.65 (t, 6H, J = 1.4 Hz), 0.63 (s, 6H). Lu2(L3)3- (TOF MS (ESI) m / z [M+2H]2+C9oH46Ni2024SeLu2-2H20 (Calc.)1128.3234, (Found) 1128.3258.Example 26: Synthesis of [(Er0 13Ybo.88)2(L3)3(H20)]
[0162] Aliquots of 3,4-diaminobenzonitrile (0.100 g, 0.751 mmol), TEA (352 μL, 2.528 mmol), and sodium 5-formyl-6-hydroxy naphthalene-2-sulfonate (0.346 g, 1.264 mmol) were added to 30 mL of MeOH in a 100 mL round bottom flask until dissolved. Ln(lll) chloride solutions, in MeOH (10 mL), containing a mixture of Yb(lll) and Er(lll) (Yb: 0.379 mmol, 0.1469 g; Er: 0.0420 mmol, 0.0160 g) were added to the solution of the deprotonated ligand in 2:3 (Ln: L3) molar ratio, and kept under stirring for 24h at 40°C to produce a yellowish-brown precipitate. The resulting solid was filtered and washed with hexanes to yield a greenish brown powder (0.160 g, 63 %). Example 26 was characterized the following results: FT-IR (v, cm-1) 3014 (C-H); 2229 (C=N); 1603 (C=N); 1357, 1099 (SO3’). ICP-MS- (87.50±0.35) % Yb, (12.50±0.05) % Er.Example 27: Synthesis of [Ln2(L4)3(H2O)]
[0163] 4-Bromo-1,2-diaminobenzene (0.100 g, 0.535 mmol), TEA (298 μL, 2.14 mmol), and sodium 5-formyl-6-hydroxy naphthalene-2-sulfonate (0.293 g, 1.07 mmol) were added to 30 mL of MeOH in a 100 mL round bottom flask until dissolved. Two third equivalents of Ln(lll) chloride (Ln(lll) = Er(lll), Gd(lll), Yb(lll)) (0.356 mmol) dissolved in MeOH (10 mL) were added to the reaction mixture and kept under stirring for 24h at 40°C to produce solid precipitates. The resulting solids were filtered and washed with hexanes.
[0164] In one or more embodiments, the synthesis yields: Er2(L4)3: 0.151 g, 35 %, Gd2(L4)3: 0.208 g, 48 %, Yb2(L4)3: 0.184 g, 42 %. Example 27 was characterized byPATENTAttorney Docket No.: TXTU / 0012PCthe following results: Er2(L4)3- (TOF MS (ESI) m / z [M+2H]2+C₈₄H₄₆N₆O₂₄S₆Br₃Er₂ (Calc.) 1144.3917 (Found) 1144.3911. Er2(L4)3- Elemental analysis for C84H46N7O24S6Br3Na6Er2'9ErCl3-6NEt3-25NaCI (Calc. %) C, 20.61; H, 1.96; N, 2.67 (Found %) C, 20.67; H, 1.96; N, 2.61. Gd2(L4)3- (TOF MS (ESI) m / z [M+2H]2+C84H50N6O24S6Br3Gd2(Calc.)1136.3848, (Found) 1136.3855. Yb2(L4)3- (TOF MS (ESI) m / z [M+2H]2+C84H46N6O24S6Br3Yb2(Calc.) 1150.8775, (Found) 1150.8774.Example 28: Synthesis of [Ln2(L5)3(H2O)J
[0165] 4-Chloro-o-phenylenediamine (0.100 g, 0.701 mmol), TEA (389 pL, 2.804 mmol), and sodium 5-formyl-6-hydroxy naphthalene-2-sulfonate (0.384 g, 1.402 mmol) were added to 30 mL of MeOH in a 100 mL round bottom flask until dissolved. Two third equivalents of Ln(lll) chloride (Ln(lll) = Er(lll), Gd(lll), Yb(lll)) (0.467 mmol) dissolved in MeOH (10 mL) were added to the reaction mixture and kept under stirring for 24h at 40°C to produce solid precipitates. The resulting solids were filtered and washed with hexanes.
[0166] In one or more embodiments, the synthesis yields: Er2(L5)3: 0.190 g, 35 %, Gd2(L5)3: 0.168 g, 31 %, and Yb2(L5)3: 0.282 g, 52 %. Example 28 was characterized by the following results: Er2(L5)3- (TOF MS (ESI) m / z [M+2H]2+C84H43N6O24S6CI3Er2(Calc.) 1075.232, (Found) 1075.2362. Er2(L5)3- Elemental analysis for C84H43N7O24S6CI3Na6Er2-11 ErCI3-9NEt3-25NaCI (Calc. %) C, 21.72; H, 2.15; N, 2.93 (Found %) C, 21.57; H, 2.33; N, 2.92. Gd2(L5)3- (TOF MS (ESI) m / z [M+2H]2+C84H46N6O24S6Cl3Gd2H2O (Calc.)1078.2125, (Found) 1078.2151. Yb2(L5)3- (TOF MS (ESI) m / z [M+2H]2+C84H46N6O24S6Cl3Yb2H2O (Calc.) 1092.6279, (Found) 1092.6239.Example 29: Synthesis of [Ln2(L6)3(H2O)]
[0167] 4-Fluoro-1,2-phenylenediamine (0.100 g, 0.793 mmol), TEA (441 pL, 3.172 mmol), and sodium 5-formyl-6-hydroxy naphthalene-2-sulfonate (0.435 g, 1.586 mmol) were added to 30 mL of MeOH in a 100 mL round bottom flask until dissolved. Two third equivalents of Ln(lll) chloride (Ln(lll) = Er(lll), Gd(lll), Yb(lll)) (0.528 mmol) dissolved in MeOH (10 mL) were added to the reaction mixture and kept under stirringPATENTAttorney Docket No.: TXTU / 0012PCfor 24h at 40°C to produce solid precipitates. The resulting solids were filtered and washed with hexanes.
[0168] In one or more embodiments, the synthesis yields: Er2(L6)3: 0.268 g, 45 %, Gd2(L6)3: 0.235 g, 40 %, and Yb2(L6)3: 0.290 g, 48 %. Example 29 was characterized by the following results: Er2(L6)3- (TOP MS (ESI) m / z [M+2H]2+C₈₄H₅₀N₆O₂₄S₆F₃Er₂ (Calc.) 1055.3046, (Found) 1055.3082. Er2(L6)3- Elemental analysis for C84H50N6O24S6F3Na6Er2-9ErCl3-9NEt3-25NaCI CH3OH (Calc. %) C, 23.31; H, 2.37; N, 3.11 (Found %) C, 23.46; H, 2.67; N, 2.95. Gd2(L6)3- (TOF MS (ESI) m / z [M+2H]2+C84H47N6O23S6F3Gd2 (Calc.) 1036.7805, (Found) 1036.7849. Yb2(L6)3- (TOF MS (ESI) m / z [M+2H]2+C84H42N6O24S6F3Yb2 CH3OH (Calc.)1073.9354, (Found) 1073.9310.Example 30: Synthesis of [Ln2(L7)3(H2O)]
[0169] 3,4-Diaminotoluene (0.100 g, 0.819 mmol), TEA (456 μL, 3.276 mmol), and sodium 5-formyl-6-hydroxy naphthalene-2-sulfonate (0.449 g, 1.638 mmol) were added to 30 mL of MeOH in a 100 mL round bottom flask until dissolved. Two third equivalents of Ln(lll) chloride (Ln(lll) = Er(lll), Gd(lll), Yb(lll)) (0.545 mmol) dissolved in MeOH (10 mL) were added to the reaction mixture and kept under stirring for 24h at 40°C to produce solid precipitates. The resulting solids were filtered and washed with hexanes.
[0170] In one or more embodiments, the synthesis yields: Er2(L7)3: 0.202 g, 33 %, Gd2(L7)3: 0.222 g, 37 %, and Yb2(L7)3: 0.196 g, 32 %. Example 30 was characterized by the following results: Er2(L7)3- (TOF MS (ESI) m / z [M+2H]2+C87H56N6O24S6Er2 (Calc.)1048.7315, (Found) 1048.7314. Er2(L7)3- Elemental analysis for C87H56N7O24S6Na5Er2-12ErCI3-4NEt3-27NaCI-7H2O (Calc. %) C, 17.48; H, 1.76; N, 2.05 (Found %) C, 17.45; H, 1.72; N, 2.02. Gd2(L7)3- (TOF MS (ESI) m / z [M+2H]2+C87H58N6O24S6Gd2 (Calc.) 1039.5642, (Found) 1039.5623. Yb2(L7)3- (TOF MS (ESI) m / z [M+2H]2+C87H56N6O24S6Yb2(Calc.) 1054.3073, (Found) 1054.3087.Example 31: Synthesis of [Ln2(L8)3(H2O)JPATENTAttorney Docket No.: TXTU / 0012PC
[0171] 3,4-Diaminoanisole (0.100 g, 0.723 mmol), TEA (402 pL, 2.892 mmol), and sodium 5-formyl-6-hydroxy naphthalene-2-sulfonate (0.396 g, 1.446 mmol) were added to 30 mL of MeOH in a 100 mL round bottom flask until dissolved. Two third equivalents of Ln(lll) chloride (Ln(l 11) = E(lll), Gd(lll), Yb(lll)) (0.481 mmol) dissolved in MeOH (10 mL) were added to the reaction mixture and kept under stirring for 24h at 40°C to produce solid precipitates. The resulting solids were filtered and washed with hexanes.
[0172] In one or more embodiments, the synthesis yields: Er2(L8)3: 0.130 g, 24 %, Gd2(Ls)3: 0.207 g, 38 %, and Yb2(L8)3: 0.246 g, 44 %. Example 31 was characterized by the following results: Er2(L8)3- (TOF MS (ESI) m / z [M+2H]2+C87H54N6O27S6Er2(Calc.) 1071.7617, (Found) 1071.7602. Er2(L8)3- Elemental analysis for C87H54N6O27S6NasEr2-13ErCl3-12NEt3-24NaCI (Calc. %) C, 22.52; H, 2.72; N, 3.00 (Found %) C, 22.58; H, 2.78; N, 2.98. Gd2(L8)3- (TOF MS (ESI) m / z [M+2H]2+C87H49N6O27S6Gd2 CH3OH (Calc.) 1074.3476, (Found) 1074.3480. Yb2(L8)3- (TOF MS (ESI) m / z [M+2H]2+C87H53N6O27S6Yb2(Calc.) 1076.0286, (Found) 1076.0286.Example 32: Synthesis of [Ln2(L9)3(H2O)]
[0173] 3,4-Diaminobenzenesulfonic acid (0.100 g, 0.531 mmol), TEA (295 pL, 2.124 mmol), and sodium 5-formyl-6-hydroxy naphthalene-2-sulfonate (0.291 g, 1.062 mmol) were added to 30 mL of MeOH in a 100 mL round bottom flask until dissolved. Two third equivalents of Ln(III) chloride (Ln(lll) = Er(lll), Gd(lll), Yb(lll)) (0.354 mmol) dissolved in MeOH (10 mL) were added to the reaction mixture and kept under stirring for 24h at 40°C to produce solid precipitates. The resulting solids were filtered and washed with hexanes.
[0174] In one or more embodiments, the synthesis yields: Er2(L9)3: 0.217 g, 50 %, Gd2(L9)3: 0.230 g, 54 %, and Yb2(L9)3: 0.162 g, 37 %. Example 32 was characterized by the following results: Er2(L9)3- (TOF MS (ESI) m / z [M+2H]2+C84H43N6O33S9Er2(Calc.) 1143.9826, (Found) 1143.9868. Er2(L9)3- Elemental analysis for C84H43N8O33S9Na6Er2-22ErCI3-6NEt3-27NaCI-16H2O (Calc. %) C, 13.16; H, 1.66; N, 1.85 (Found %) C, 13.16; H, 1.52; N, 1.79. Gd2(L9)3- (TOF MS (ESI) m / z [M+2H]2+PATENTAttorney Docket No.: TXTU / 0012PCC84H49N6O33S9Gd2(Caic.) 1139.5276, (Found) 1139.5356. Yb2(L9)3- (TOF MS (ESI) m / z [M+2H]2+C84H42N6O33S9Yb2(Calc.) 1148.9240, (Found) 1148.9218.Photophysical Characterization of Multi-metallic Naphthylsalophen Sulfonate Ln(lll) Complexes [Ln2(Lx)3(H2O)]Examples
[0175] The suitability of the Ln(lll) complexes as Ln(lll) emitters through the antenna effect was assessed through the energies of singlet and triplet states, as shown in Table 5, which were obtained from the fluorescence and phosphorescence of the analogous Gd(lll) complexes. Table 5 shows the singlet (1S) and triplet (3T) state energies of the ligands, excited state lifetime (T), and quantum yield of sensitized emission (pLni). The singlet energies range from 19,010 to 27,320 cm1. The triplet energies of L3-L6and L9, located at 16,560 to 17,350 cm1, show that these ligands are able to sensitize Yb(lll) and Er(lll), as their emissive states2F5 / 2and4I13 / 2are about 10,000 cm-1and about 7,000 cm’1respectively. The triplet energies of L1, L2, L7, and L8range from 18,950 to 22,850 cm1and thus, have poor energy matches to sensitize Yb(lll) and Er(lll).Table 5PATENTAttorney Docket No.: TXTU / 0012PCaDetermined from the fluorescence and phosphorescence spectra at 77 K after deconvolution and indicated as the zero-phonon band.bln MeOH.PATENTAttorney Docket No.: TXTU / 0012PC
[0176] The trends in energies of1S and3T states were correlated to the electronegativity of the functional group in the backbone of the ligand shown in Figure 3. The excited state energies decrease with increasing electronegativity, as has been observed in other Ln(lll) complexes, and the trend is most pronounced for the less electronegative substituents.
[0177] Exciting the Ln(lll) complexes in DMSO at 370-450 nm leads to the characteristic Er(lll) and Yb(lll)-centered emission corresponding to the transitions4li3 / 24li5 / 2 and2Fs / 22Fz / 2, respectively. The broad excitation spectra are consistent with sensitization through the ligands. The excited state lifetimes and quantum yields of sensitized emission for Yb(lll) are listed in Table 5. The excited state decay curves of the2F5 / 2→2F7 / 2transition were fitted with a bi-exponential, which is consistent with two Yb(lll) coordination environments; while the attempt to grow X-ray quality single crystals is ongoing, the double exponential lifetimes are evidence that these Ln(lll) complexes are expected to display the 3:2 ligand-to-metal stoichiometry observed in the previously disclosed isolated Ln(lll) complexes.
[0178] The low quantum yields are attributed to the large energy gaps between the ligand excited states and the2F5 / 2state of the metal ion and the Ln(lll) complexes with the smaller gaps show the larger quantum yields of sensitized emission, as shown in Figure 19. Figure 19A shows3T as a function of electronegativity and Figure 19B shows the quantum yield of sensitized emission as a function of3T.
[0179] Due to the assumed 3:2 ligand-to-metal stoichiometry, the disclosed Ln(lll) complexes have two metal ions in close proximity and are expected to show UC emission. The UC emission of the Er(lll) and the mixed Ln(lll) complexes were tested in the solid state. Figure 20A shows a two-photon UC emission spectrum of Er2(L2)3 in the solid state using variable laser power. Figure 20B shows the logarithmic plot of the emission intensity of the transitions2Hn / 2 —>4115 / 2 (black squares)4S3 / 2→4I15 / 2(green circles), and4F9 / 2→4I15 / 2(red squares) as a function of the laser power P ( exc = 980 nm, P = 0.593-2.500 W, solid-state). [Er2(L2)3(H2O)] was excited at 980 nm into the Er(lll)4lis / 2 -4111 / 2 transition, and the resulting spectra emission showed the characteristic Er(III) -centered transitions in the blue2H11 / 24115 / 2, green4S3 / 2→4I15 / 2, and red4F9 / 2→4I15 / 2, as shown in Figure 20A. The logarithmic quadratic dependencePATENTAttorney Docket No.: TXTU / 0012PCof the emission intensity (I) on laser power (P), as shown in Figure 20B, confirms the 2-photon nature of the process. UC emission was observed with power densities as low as 1.48 W / cm2. UC emission was observed for [Er2(L3)3(H2O)], [(Ero.i8Ybo.82)2(L')3(H20)], and [(Ero.i3Ybo.87)2(L3)3(H20)] with power densities between 1.48 and 6.25 W / cm2.
[0180] Figure 21 shows the two-photon UC emission spectra of [Er2(L2)3(H2O)] in the H2O and D2O [Er2(L2)3 ] = 3.7 mM (i - 980 nm, P - 2.500 W, integration time: 20 s). [Er2(L2)3(H2O)] demonstrated the most intense UC emission in the solid state, thus [Er2(L2)3(H2O)] was investigated for the ability to display UC emission in aqueous solutions. UC was observed for concentrations higher than 3.7 mM in both water and D2O, as shown in Figure 21 at intensities about 25x lower than in the solid state. As in the solid state, the transition4S3 / 2→4I15 / 2in the green was the most intense, followed by the transition4F9 / 2→4I15 / 2in the red.
[0181] Figure 22 shows the two-photon UC emission spectra of Er2(L3)3 (solid) and [(Er0.1Yb0.9)2(L3)3] (dashed) in the solid state. (Aexc= 980 nm, P = 2.500 W, integration time: 20 s). While [Er2(L3)3(H2O)] demonstrated UC in solid and water, the mixed Ln(lll) complexes exhibit higher UC emission intensity than dierbium complexes, as shown in Figure 22.
[0182] Ln(lll) complexes Er2(L3)3and [(Ero.iYbo.9)2(L3)3(H20)] share the same ligand design and both demonstrated UC emission, but the metal centers are different. Er2(L3)3 is a dierbium complex, while [(Er0.1Yb0.9)2(L3)3(H2O)] is heterobimetallic with 90% Yb(lll) and 10% Er(lll). When comparing the emission spectra of [Er2(L3)3(H2O)] and [(Eroi3Ybo87)2(L3)3(H20)], the mixed Ln(lll) complex exhibited higher emission intensity. The decrease in cross- relaxation between adjacent Er(lll) and the higher absorption coefficient of Yb(III) is attributed to the difference in exhibited emission intensity. The short distance between the adjacent erbium atoms leads to an increase in energy transfer and, subsequently, a decrease in emission intensity. Hence, the isolated 90% Yb and 10% Er complex decreased the cross- relaxation probability and improved UC emission. The energy gap between the excited state (2F5 / 2) of Yb(III) and the ground state (2F7 / 2) is equal to that of a 980 nm photon. Additionally, the2F7 / 2PATENTAttorney Docket No.: TXTU / 0012PCto2FS / 2 transition matches the energy levels of Er(lll) (4I11 / 2), which helps improve the probability of UC emission.
[0183] Figure 23A shows normalized UC emission spectra for all substituted Ln(lll) complexes disclosed above. Figure 23B shows a comparison of electron withdrawing groups (EWGs) and electron donating groups (EDGs) (Xexc = 980 nm, P = 2.500 W, integration time: 20 s). The UC emission of complexes with ligands functionalized with EWGs and EDGs was studied, which included a variety of various substituents from halogens to methyl, methoxy, and sulfonate groups. While the ligands used for UC luminescence are optically inert, they play a role in the crystal-field environment surrounding the Ln(lll), and rigid hosts help decrease vibrational quenching. Moreover, the ligands dictate the interionic distance and spatial arrangements of the adjunct lanthanide atoms. Lower symmetry Ln(III) complexes should achieve optimal UC emission.
[0184] Electron donating and withdrawing groups affect UC emission. In the systems substituted by a strong electron-withdrawing group (i.e., -CN) all three transitions of Er(lll) are observed with suitable resolution and intensity. This Er(lll) transition is because electron-withdrawing groups can improve electric dipole transitions. The Ln(lll) complexes with the electron-withdrawing cyano groups (blue and yellow) ligands showed the highest intensity and the best resolution, as shown in Figures 23A and 23B. The Ln(lli) complexes with ligands substituted with EDGs or weak EWGs exhibited poor UC emission. For the EWGs -F and -Cl, only one transition was observed, which we attribute to coupling between4S3 / 2and2Hn / 2 transitions. Only the4Ss / 24115 / 2 transition at about 50 counts per second (CPS) is seen for -CH3, an EDG, and -H. The methoxy-functionalized Ln(lll) complexes exhibited the4F9 / 24hs / 2 transitions; however, the other transitions have poorer resolution. Based on the above results, it can be shown that UC emission is affected by the local environment of the Ln(lll).Biological Applications
[0185] Ln(lll) complexes, including the above disclosed examples, are of interest for use in biological and biomedical applications, including optical imaging of cells, tissues, and whole organisms. In particular, the disclosed Ln(lll) complexesPATENTAttorney Docket No.: TXTU / 0012PCcomprising naphthylsalophen ligands exhibit photophysicai properties that enable their use as contrast agents for high-sensitivity imaging.
[0186] In one or more embodiments, a lanthanide(ll I) complex is administered to a biological sample, including but not limited to cultured cells, tissue samples, or in vivo biological tissues. The lanthanide(lll) complex may be delivered via injection, incubation, perfusion, or other suitable delivery techniques. Following administration, the biological sample comprising the lanthanide(lll) complex is irradiated with electromagnetic radiation at a first wavelength. The electromagnetic radiation may comprise NIR radiation, visible light, ultraviolet light, or combinations thereof, with NIR excitation being particularly advantageous for biological applications due to reduced scattering and increased tissue penetration.
[0187] The lanthanide(lll) complex at least includes the ligand, such as the naphthylsalophen ligand disclosed above, coordinated to one or more lanthanide ions that function cooperatively as a sensitizer and an activator. In one or more embodiments, a first lanthanide ion, such as ytterbium(lll), functions as the sensitizer by efficiently absorbing incident electromagnetic radiation, particularly in the nearinfrared region. A second lanthanide ion, in multi-Ln(lll) metal complexes, such as erbium(lll) or thulium(lll), functions as the activator and is configured to emit up-converted radiation following energy transfer from the sensitizer. In one or more embodiments, the ligand(s) within the complex are the sensitizer and the Ln metal is the activator.
[0188] Upon excitation, the sensitizer component absorbs one or more photons and undergoes an energy transfer process to the activator component. Through sequential photon absorption and energy transfer steps, the complex undergoes photon up-conversion, resulting in emission of electromagnetic radiation at a second wavelength having higher energy than the excitation wavelength. In certain embodiments, the emitted radiation is within the visible spectrum, including red, green, and / or blue emission, although emission in other spectral regions is also contemplated.
[0189] In some embodiments, the Ln(lll) complexes are configured for excitation with NIR and emission of light in the visible region, thereby enabling visualization withPATENTAttorney Docket No.: TXTU / 0012PCstandard optical detection systems while minimizing photodamage and autofluorescence associated with higher-energy excitation sources. The up- conversion process allows for deep tissue imaging and improved signal-to-noise ratios relative to conventional fluorophores.
[0190] Cell-based studies demonstrate that the disclosed Ln(lll) complexes are capable of cellular uptake and intracellular localization without significant loss of luminescent properties. In particular, cultured cells incubated with the Ln(lll) complexes exhibit detectable up-converted emission under near-infrared excitation, confirming that the Ln(lll) complexes retain functionality in biologically relevant environments. Additionally, the observed luminescence within cells indicates that the Ln(lll) complexes are sufficiently stable under physiological conditions and are not substantially quenched by aqueous media or intracellular components.
[0191] In certain embodiments, the Ln(lll) complexes exhibit low cytotoxicity at concentrations effective for imaging, as evidenced by cell viability assays performed following incubation with the Ln(lll) complexes, as disclosed above. This biocompatibility, combined with efficient photon up-conversion, supports their use as imaging agents for live-cell imaging and potential in vivo applications.
[0192] Accordingly, the Ln(lll) complexes described herein may be utilized in a variety of biological applications, including but not limited to fluorescence imaging, bioassays, diagnostic imaging, tracking of cellular processes, and visualization of tissue morphology. The ability to tune excitation and emission wavelengths through ligand design and lanthanide selection further enables customization of the Ln(lll) complexes for specific biological imaging modalities.
[0193] Overall, embodiments of the present disclosure generally relate to water- soluble Ln(lll) complexes. Specifically, embodiments of the present disclosure may be useful in up-conversion processes, particularly for use in bioimaging applications. The disclosed isolated Ln(lll) complexes exhibit at least red, green, and blue up- conversion emission upon excitation with power densities as low as 0.593 W / cm2and as high as 2.50 W / cm2. For example, the Ln(lll) complex [Er2(L1)3H2O] and [(Ero.iYbo.9)2(L3)3(H20)] exhibited an intense up-conversion emission in solid-state and also exhibited up-conversion emission in aqueous solution. Further, a plurality of thePATENTAttorney Docket No.: TXTU / 0012PCLn(lll) complexes are biocompatible as evidenced with the disclosed cell studies. The Ln(lll) complexes are operable to show UC emission within the cells, which allows the disclosed Ln(lll) complexes to be used to image cells in two-photon experiments, and, therefore, be applicable to bioimaging applications and other imaging fields where irradiation with low energy exciting radiation might be advantageous.
[0194] Certain embodiments and features have been described using a set of numerical upper limits and a set of numerical lower limits. It should be appreciated that ranges including the combination of any two values, e.g., the combination of any lower value with any upper value, the combination of any two lower values, and / or the combination of any two upper values are contemplated unless otherwise indicated. Certain lower limits, upper limits, and ranges appear in one or more claims below.
[0195] Certain embodiments and features have been described using the term “about” with a numerical value. When the term “about” is used in conjunction with a numerical value, it should be construed as indicating any numerical value within 10% of the stated numerical value.
[0196] The following disclosure describes systems, methods, and apparatuses used for delivery of chemical precursors. Certain details are set forth in the following description and in the Figures to provide a thorough understanding of various implementations of the disclosure.
[0197] Many of the details, dimensions, angles, and other features shown in the Figures are merely illustrative of particular implementations. Accordingly, other implementations can have other details, components, dimensions, angles, and features without departing from the spirit or scope of the present disclosure. In addition, further implementations of the disclosure can be practiced without several of the details described below.
[0198] While the foregoing is directed to embodiments of the present disclosure, other and further embodiments of the disclosure may be devised without departing from the basic scope thereof, and the scope thereof is determined by the claims that follow.
Claims
PATENTAttorney Docket No.: TXTU / 0012PCWhat is claimed is:
1. A composition, comprising:a lanthanide(lll) complex represented by Formula (I):[Ln2(Lx)3(H2O)],wherein, each Ln is independently a lanthanide(lll) ion; andLxis a ligand, each of the ligands independently comprises an imidazolium- functionalized multidentate ligand derived from an imidazole-substituted aldehyde and a diamine, a benzenetriol-derived multidentate ligand comprising a 1,2,3- trihydroxybenzene moiety, a naphthylsalophen ligand functionalized with one or more sulfonate groups,wherein R is a hydrogen or NaSO3.
2. The composition of claim 1, wherein at least one of the lanthanide(lll) ions comprises ytterbium (Yb(lll)), erbium (Er(lll)), gadolinium (Gd(lll)), lutetium (Lu(lll)), yttrium (Y(l 11)) or a combination thereof.PATENTAttorney Docket No.: TXTU / 0012PC3. The composition of claim 1, wherein the composition further comprises three lanthanide(III) ions.
4. The composition of claim 1, wherein the two lanthanide(lll) ions are different lanthanide (III) ions.
5. The composition of claim 1, wherein the two lanthanide(lll) ions are the same lanthanide(III) ions.
6. The composition of claim 1, wherein the composition is water-soluble at about 10mg per mL.
7. The composition of claim 1, wherein at least one of the ligands is a sensitizer, at least one of the Ln(lll) ions is an activator, and wherein the sensitizer is operable to absorb near infrared light and the activator is operable to emit a higher-energy photon.
8. The composition of claim 1, wherein the at least one ligand is a sulfonated ligand.
9. A composition, comprising:a lanthanide(lll) complex represented by Formula (I):[Ln2(Lx)3(H2O)],wherein each Ln2 is independently a lanthanide(III) ion; andeach L is independently a ligand.
10. The composition of claim 9, wherein at least one of the lanthanide(lll) ions comprises ytterbium (Yb(lll)), erbium (Er(lll)), gadolinium (Gd(lll)), lutetium (Lu(lll)), yttrium (Y(lll)) or a combination thereof.
11. The composition of claim 9, wherein the two lanthanide(lll) ions are different lanthanide(lll) ions.PATENTAttorney Docket No.: TXTU / 0012PC12. The composition of claim 9, wherein the two lanthanide(ll I) ions are the same lanthanide(III) ions.
13. The composition of claim 9, wherein the lanthanide(lll) complex is represented by Formula (II):
14. The composition of claim 9, wherein the lanthanide(l 11) complex is represented by Formula (III):PATENTAttorney Docket No.: TXTU / 0012PC15. The composition of claim 9, wherein the lanthanide(i 11) complex is represented by Formula (IV):PATENTAttorney Docket No.: TXTU / 0012PC16. A composition, comprising:a lanthanide(l 11) complex represented by Formula (V):[Ln2(L’x)3H2O],wherein, each Ln is independently a lanthanide(lll) ion; andeach L’xis independently a sulfonated ligand.
17. The composition of claim 16, wherein at least one of the lanthanide(lll) ions comprise ytterbium (Yb(lll)), erbium (Er(lll)), gadolinium (Gd(lll)), lutetium (Lu(lll)), yttrium (Y(lll)) or a combination thereof.
18. The composition of claim 16, wherein at least one of the ligands is a sensitizer, at least one of the Ln(lll) ions is an activator, and wherein the sensitizer is operable to absorb near infrared light and the activator is operable to emit a higher-energy photon.
19. The composition of claim 16, wherein the lanthanide(lll) complex is represented by Formula (XIII):PATENTAttorney Docket No.: TXTU / 0012PCwherein each R1and each R2independently comprises a hydrogen (-H), a methyl group (-CH3), a methoxy group (-OCH3), a cyano group (-CN), a fluoro group (-F), a chloro group (-CI), a bromo group (-Br), a sulfonic acid group (-SO3H), or two cyano groups.
20. The composition of claim 16, wherein the composition is water-soluble at about 10mg per mL
